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Abstract 
The beneficial role of exercise in chronic disease management is well recognized, 
but the challenge of effective exercise prescription within primary care persists. 
Initiatives requesting clinicians to prescribe specific exercises to their patients has left 
two underlying questions: 1) Who is the most appropriate clinician to prescribe exercise 
to meet the unique needs of individuals living with more than one disease; 2) How does 
this clinician ensure appropriate and safe exercise prescriptions are provided?  
Three studies were completed to begin addressing the aforementioned questions. 
A nationally distributed survey compared exercise curricula between physiotherapy, 
nursing, and medical programs, while a systematic literature review showed overlapping 
physiological and subjective markers that clinicians may use to define safe exercises for 
individuals living with multiple chronic diseases. Finally a novel approach and a 
preliminary tool are presented to help guide how exercise prescription could be 
implemented in primary care.  
 Findings suggest that PTs should lead the exercise prescription movement in 
primary care with nurses and physicians as exercise advisors or facilitators. Evidence 
from this thesis supports improving access to PT in primary care. Also, exercise 
prescription in individuals with multiple chronic diseases from a body-systems 
perspective is proposed, rather than solely relying on the dominantly available single-
disease exercise guidelines. Finally, a newly developed exercise prescription approach is 
presented, which takes into account the advisors role in exercise prescription, while a 
preliminary tool is proposed that considers physiological and personal profiles of 
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individuals who have more than one chronic disease, to guide clinicians in developing 
tailored exercise prescriptions in the primary care context.  
Keywords: chronic disease, exercise, curriculum, prevention & control, disease 
management, exercise prescription, primary care, health promotion.  
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Chapter 1: General Introduction  
It is estimated that 56% of two million Ontarians who are currently over the age 
of 65 have at least two chronic diseases1-3 with direct and indirect healthcare costs 
surpassing $90 billion.2 Although chronic diseases are among the most common and 
costly health problems in Canada, their complications may be prevented and controlled 
through appropriate healthcare strategies. 
The beneficial role of exercise for prevention and management of chronic diseases 
is well recognized in numerous exercise guidelines published by industry and academic 
leaders.3-5 All currently available exercise guidelines are geared towards the general 
population in a specific age bracket, or to those living with a single disease. However, in 
reality over 50% of older adults are affected by more than a single chronic disease,6 
making it challenging to translate the currently available evidence on an individual level. 
The need to tailor exercise recommendations on an individual basis has been identified as 
necessary when working with clinical populations.5,7,8 Despite this acknowledgement, an 
effective strategy to accomplish such a task is yet to be established.  
Although initiatives such as Exercise Is Medicine (EIM) by the American College 
of Sports Medicine9 have emerged, requesting clinicians to prescribe specific exercises to 
their patients has left two underlying questions: 1) Who is the most appropriate clinician 
to prescribe exercise to meet the unique needs of an individual living with more than one 
chronic disease; 2) How does this clinician ensure appropriate and safe exercise 
prescriptions are provided?  
It has been previously suggested that physicians10-12 and nurses13 are potential 
candidates to provide individually tailored exercise prescriptions. However, time 
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demands along with lack of confidence and formal exercise science knowledge have 
repeatedly emerged in the literature as barriers for physicians to effectively and 
confidently prescribe exercise within their regular practice.13 This may not be surprising 
given that approximately 87% of US medical schools do not include instructions on the 
health benefits of exercise, nor do they offer any kind of exercise curriculum. 
Furthermore, 76% of these schools have no plans to include such a curriculum in the 
future.14  Similarly, researchers from the UK obtained a 100% response from all medical 
programs in England and found that exercise was limited or completely absent from the 
medical schools’ curricula.15  
 A recent systematic review recognized the potential limitations of solely relying 
on physicians to prescribe specific exercises to clients.13 These authors suggested nurses 
as being the most appropriate healthcare provider to incorporate exercise counseling to 
clients as a component of their health promotion role.13 However, high burnout rates and 
absenteeism have been reported with seasoned, as well as recent nursing graduates, in 
part attributed to the increasing job demands and complexities of their role.16 
Furthermore, the nursing profession does not typically offer extensive (or any) training in 
exercise science.17 Placing another obligation, such as exercise prescription, onto already 
overtaxed healthcare providers stands the risk of further exacerbating previously 
identified barriers and limitations (e.g., time-demands and expertise gap). 
Recognizing the limitations of the aforementioned primary care providers’ role in 
exercise prescription, the hypothesis presented in this thesis is that the ideal primary care 
provider that may effectively prescribe and monitor exercise are physical therapists, who 
need to be considered as core team members for all chronic disease management 
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interventions. The reasoning behind this hypothesis is evidence-informed and grounded 
in the unique and relevant role of physiotherapists, as defined by the Canadian 
Physiotherapy Association:18 
“Physiotherapy is a primary care, autonomous, client-focused health profession 
dedicated to improving quality of life by: Promoting optimal mobility, physical activity 
and overall health and wellness [through]; 
- Education, consultation, health promotion and prevention services. 
- Personalized therapeutic exercise including testing and conditioning, 
neurotherapeutic approaches to improve strength, range of motion, and 
function. 
- Preventing disease, injury, and disability; 
- Managing acute and chronic conditions, activity limitations, and 
participation restrictions; 
- Improving and maintaining optimal functional independence and physical 
performance; 
- Rehabilitating injury and the effects of disease or disability with therapeutic 
exercise programs and other interventions; and 
- Educating and planning maintenance and support programs to prevent re-
occurrence, re-injury or functional decline.” 
 
Based on the description of physical therapy practice and given the previous 
evidence on positive impact of physiotherapy interventions in individuals with chronic 
disease(s),19,20 physiotherapists may be best prepared to address the challenges associated 
with exercise prescription within the primary care context for the purpose of chronic 
disease prevention and management. Primary care context refers to services that the 
public can directly access, such as prevention and treatment of common diseases, health 
promotion, palliative care, and rehabilitation. In Canada, family physicians, nurses and 
general medical practitioners, along with physical therapists are examples of 
professionals who deliver primary care services.21  
The context of primary care is changing with a shift towards a team-based 
approach to healthcare delivery. There is now consensus that having such an approach 
will increase access to services and also improve health promotion as well as chronic 
 
 
4 
disease management.21 When identifying who should comprise core members of such 
teams, consideration ought to be given to a provider that is best prepared to effectively 
prescribe exercise to address the complex needs of individuals with/or at risk of chronic 
disease(s). However, at this time evidence is required to illustrate the primary care 
provider who is best prepared to lead exercise prescription within the primary care 
context for the purpose of chronic disease prevention and management. This initiative fits 
well with the mandate of Health Canada’s health care reform, which begins addressing 
the long-called improvements in health promotion, disease prevention, and chronic 
disease management within the primary care context.22,23  
A mixed-methods design was employed to begin addressing the aforementioned 
limitations and knowledge gaps. Brief descriptions are provided below, but each study is 
further elaborated in subsequent chapters of this thesis.  
Study 1: The “Who” of Exercise Prescription  
Study 1 is presented in chapter 2 of this thesis. This study is divided into two 
phases. Phase one includes the distribution of a survey to directors of physiotherapy, 
medical, and nursing programs across Canada. Descriptive statistics with chi square 
analysis of key findings were used to demonstrate the amount of time and resources 
devoted to teaching respective professional programs’ students about exercise. 
Furthermore, thematic coding was completed for the questions that provided text-boxes 
for participants to share further comments.  
In phase two, a detailed document analysis was completed to determine the 
exercise education backgrounds of physiotherapy students in Ontario attained prior to 
commencing a Masters’ program in physical therapy. Specifically, the Ontario 
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Rehabilitation Sciences Programs Application Service (ORPAS) data between 2008-2012 
were reviewed to determine the specific undergraduate education of students accepted 
into one of the four Ontario-based Masters’ program in physiotherapy. For the purpose of 
this study, data (i.e., pre-Masters’ education in physiotherapy) reviewed focused mainly 
on Ontario-based PT programs rather than Canada. This was done for two main reasons: 
1) limited funding; 2) Ontario has the highest concentration of physiotherapy programs, 
which are attended by students from across Canada providing a representative sample of 
the type of educational background attained by students who choose to pursue post-
graduate education in physiotherapy.  
Study 2: The “What” of Exercise Prescription  
The second study includes a systematic review that is presented in chapter 3 of 
this thesis. The systematic review was completed between September 2013 until August 
2014 and it presents the evidence on exercise prescription for three major chronic 
diseases from three different systems of the body: type 2 diabetes mellitus (endocrine 
system), coronary artery disease (cardiovascular system), and chronic obstructive 
pulmonary disease (respiratory system). The purpose of this review was to extrapolate 
key markers that ought to be monitored for safe exercise prescription in populations with 
more than a single chronic disease. It introduces a novel perspective on exercise 
prescription considerations from a physiological systems perspective, rather than the 
currently dominant one, which focuses on exercise guidelines taking into account a single 
chronic disease.  
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Study 3: The “How” of Exercise Prescription  
The third study, detailed in chapter 4 of this thesis introduces an innovative 
exercise prescription approach to begin addressing the underlying question of how to 
tailor appropriate exercises when working with individuals living with multiple chronic 
diseases, rather than solely relying on guidelines that are often too broad or relevant for 
the needs of a person living with a single disease. The proposed exercise prescription 
approach first discusses how exercise prescription may be incorporated within primary 
care, and then conceptual algorithms are provided to discuss how a future electronically 
based tool could assist in the production of a personalized exercise prescription. A 
person’s physiological and personal profile, coupled with clinical reasoning and client 
collaboration are all key components included in the proposed tool to help inform the 
exercise prescription decision-making process.  
Details of each study are summarized in subsequent chapters, presented in 
individual manuscript formats, while the discussion chapter shares final insights gained 
from completing this research, including some of the limitations encountered throughout 
the process, as well as potential future research directions. 
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Chapter 2: Formal Exercise Curricula in Canadian Physiotherapy, Nursing, and 
Medical Schools 
Introduction 
Addressing risk factors of chronic disease means that approximately 80% of 
leading chronic diseases, such as premature heart disease, stroke, and diabetes could be 
prevented.1 Although this is well known and exercise is also recognized as a key 
cornerstone in chronic disease management, effective implementation of exercise within 
primary care continues to be a challenge. According to Health Canada,2 primary care is 
the element within primary health care that focuses on health care services, including 
health promotion, illness and injury prevention, and the diagnosis and treatment of illness 
and injury. While primary health care refers to an approach to health and a spectrum of 
services, including all services that play a part in health, such as income, housing, 
education, and environment. Thus, for the purpose of this paper, primary care is the 
operational definition used to describe the practice context relevant for physicians, 
nurses, and physiotherapists.  
Several recent initiatives, such as exercise guidelines for specific groups, a 
developing role for kinesiologists and clinical exercise physiologists (still to be fully 
determined), and the “exercise is medicine” movement have attempted to bridge the gap 
between knowing exercise is beneficial and incorporating it within primary care.3-5 In 
instances with more complex healthcare needs, exercise guideline readers will often be 
referred to speak with their healthcare provider for additional guidance and support 
regarding safe and appropriate exercise recommendations within a clinically monitored 
setting. However there are two assumptions that ought to be recognized within such a 
referral: 1) the reader will know which primary care provider to turn to for additional 
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exercise recommendations for their unique health needs, and 2) the healthcare 
professional is prepared to provide appropriate, safe, and effective exercise 
recommendations.  
From the relevant literature, we found that several authors6-10 made compelling 
advocacy for including physicians to play a key role in exercise counseling and 
prescription, while others11 suggest nurses incorporate exercise recommendations as part 
of their health promotion role. However, in practice few physicians consider exercise 
during their examinations,12 which is not surprising given that medical schools in the 
United Kingdom and United States have limited (if any) exercise education within their 
curriculum13,14 and minimal opportunity to design a specific exercise prescription.12 
Notably, this type of research has not yet been reported for Canadian medical or nursing 
schools. Thus, given the acknowledged benefits of exercise, along with the initiatives to 
incorporate exercise prescription within the primary care context, evidence is needed to 
determine which healthcare provider is formally trained and thus best prepared to 
implement effective exercise prescription within our present healthcare system.  
A two-phase study was conducted to compare physiotherapy (PT), nursing (RN) 
and medical (MD) program curricula to determine whose students may be best prepared 
to prescribe exercise within primary care for the purpose of chronic disease prevention 
and management. In phase 1 a survey was distributed to compare the formal exercise 
curriculum offered in Canadian PT, RN, and MD programs. Phase 2 included an in-depth 
document review of PT programs listed in the Ontario Rehabilitation Sciences Program 
Application Service (ORPAS) from 2008-2012, in order to determine the typical 
educational background of students coming into physiotherapy programs. 
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Methods 
We developed a survey for phase 1 based on previous literature13 and feedback 
from several researchers with questionnaire experience to cover the basic aspects of 
exercise knowledge gained during the duration of the professional program. The study 
has been approved by the appropriate ethics review board(s) (Appendix A), informed 
consent has been obtained for all participants and the study conforms to the Human and 
Animal Rights requirements of the February 2006 International Committee of Medical 
Journal Editors' Uniform Requirements for Manuscripts Submitted to Biomedical 
Journals.  
An electronic version of the survey was prepared for distribution to potential 
study participants following ethics approval. A telephone call was made to 15 PT, 17 
MD, and 24 RN schools across Canada, to introduce the study and confirm the most 
appropriate person who could comment on curriculum details for their respective 
program. Director is the term used throughout the paper to define this person, even 
though the official titles varied (e.g., Deans, Program Chairs, Leads, Directors, etc.,). 
From the initial contact made with the administrator, the appropriate person was secured 
for 10 PT, 12 MD, and 17 RN programs. Each of these program directors was e-mailed a 
copy of the study’s cover letter, consent, and the electronic uniform resource locator 
(URL) directing participants to the online survey, which took a maximum of 10 minutes 
to complete. The URL enabled automatic data collection within the appropriate, 
electronic, password-protected folders labeled PT, RN, or MD, which helped minimize 
human error during data tabulation and analysis. One week after the initial contact, a 
follow-up e-mail was sent to all identified directors, which was subsequently followed by 
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a reminder telephone call one week later. Participants were given eight weeks to 
complete the survey, with a reminder e-mail sent once per week.  
The questionnaire helped quantify participants’ responses based on specific 
questions from eight categories (Table 1), including: 1) beliefs about exercise 
prescription; 2) the “how” of exercise prescription; 3) safety and exercise prescription; 4) 
exercise advice, benefits, and physiological effects; 5) current exercise prescription 
curriculum; 6) future curriculum plans; 7) exercise prescription and chronic disease; and 
8) utilization of specific exercise guidelines. Open-ended free form text boxes were 
provided for further commentary that participants felt was important to share.  
Table 1: Questionnaire categories and respective survey questions used to inform each 
category 
Category  Question (#, Content) 
Beliefs about 
exercise prescription  
1) We believe that giving advice to be physically active is the same as providing a 
specific exercise prescription.  
2) We believe that teaching students how to prescribe exercises to clinical 
populations should be mandatory.  
The how of exercise 
prescription  
3) We teach students how to design an exercise program for individuals living with 
medical conditions.  
4) We teach our students to prescribe exercise(s) using specific criteria (e.g., 
frequency, intensity, sets, repetitions, duration, etc.,).  
5) We teach our students how to implement an exercise program.  
Safety and exercise 
prescription 
6) We teach our students established exercise precautions.  
7) We teach our students established exercise contraindications.  
8) We teach our students what to monitor to ensure safety during exercise. 
Exercise advice, 
benefits, and 
physiological effects  
10) Our students are taught how to advise patients about the benefits of exercise. 
11) We have dedicated lectures to teach our students the physiological effects of 
exercise on chronic disease(s). 
Current exercise 
prescription 
curriculum  
13) We have at least one course dedicated to teaching students about the benefits of 
physical activity/exercise. 
14) Exercise prescription is intergraded within mandatory courses.  
15) Our curriculum provides a sufficient amount of exercise/physical activity 
instruction.  
Future curriculum 
plans  
16) In the next 5 years we plan to have a course dedicated to teaching our students 
how to prescribe exercise/physical activity to clinical populations [i.e., individuals 
living with chronic condition(s)]. 
Exercise prescription 
and chronic disease* 
12) We teach our students how to prescribe exercise to populations living with the 
following (check all that apply): Type I diabetes; Type II Diabetes; Coronary 
Artery Disease; Stroke; Multi-System Involvement; Other  
Utilization of 
specific exercise 
9) In order to teach our students specific physical activity recommendations, we 
use exercise guidelines from the following (check all that apply): we do not use 
 
 
13 
Note: *Questions provided text boxes for participants to share additional information 
under “other”. 
Chi Square analysis with Fisher’s Exact Test was done to assess the main 
difference in responses between PT, RN, and MD program directors. Frequency analysis 
was completed and t-tests were done to compare PT and RN directors’ answers. Data 
attained from responses given by MD directors were excluded from the t-test analysis due 
to the low response rate (4/12, 33%). However, word responses were reviewed and their 
content thematically analyzed15 to illustrate perspectives shared by directors from all 
three professional programs.  
In phase 2, the Ontario Rehabilitation Programs Application Services (ORPAS) 
was e-mailed and the request for permission to review and present the data included in 
their annual report was granted without ethics approval. Information from 2008-2012 was 
reviewed to assess the formal exercise academic background (i.e., undergraduate degree), 
of students who chose to attend one of four Ontario-based, professional masters programs 
in physiotherapy. Similar information about the academic background of students 
admitted to medical schools was not made available by the Ontario Universities’ 
Application Center (OUAC), as their representative expressed that they do not release 
these details to anyone who does not have “an ongoing relationship with OUAC”. Data 
on pre-nursing education was also not obtainable, given the heterogeneity of nursing 
programs across Ontario (i.e., Community/College-based, University-based, or combined 
and graduate programs at universities).  
 
 
guidelines*  any established guidelines; American College of Sports Medicine, Canadian 
Physical Activity Guidelines, Canadian Society for Exercise Physiology, Other. 
 
 
14 
Results  
Results are presented in two main sections, including Phase 1: Survey Findings 
and Phase 2: the ORPAS document review.  
Phase 1: survey findings. Response rate and chi square analysis are described 
first. The rest of the survey findings are presented under the previously introduced 
questionnaire categories (Table 1). Although the questionnaire was e-mailed across 
Canada, program directors from different provinces were reached for each professional 
program with varying response rates (Table 2). 
Table 2: Study participants’ programs, provinces, and response rates. 
Professional 
Program  
Program Directors’ Respective Provinces Response 
Rate* 
Physiotherapy  Alberta; British Columbia; Manitoba; Quebec; Ontario  n=10, 100% 
Nursing  Alberta; British Columbia; Ontario; Saskatchewan n=10, 59% 
Medicine  Alberta; Ontario; Quebec  n=4, 33% 
*Note: Response rate is based on the responses obtained from program directors whose 
contact details were secured, not the total number of programs in all of Canada.  
Main response difference. Based on the chi square analysis using Fisher’s Exact 
Test, a statistically significant (p<0.001) difference was noted in the way the 
questionnaire was answered by PT, RN, and MD directors. 
The t-test analysis comparing PT and RN responses for the following 13 Likert-
scale survey questions, were statistically significant (range: p<0.001to p=0.008). A table 
with response frequencies can be found in Appendix B, while the t-test analysis table is 
shown in Appendix C. Despite the low response rate and exclusion of MD director 
responses from the t-test analysis, their contributions are included to illustrate key trends. 
Study participants’ comments are briefly presented in the findings and further elaborated 
in the discussion section of this paper.  
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Beliefs about exercise prescription. Question 1 and 2 from the survey (Table 1) 
assessed participants’ beliefs about exercise prescription. A majority (90%) of the 
directors for the PT and RN professional programs disagree or strongly disagree that 
advice to be physically active is the same as a specific exercise prescription. The trend 
from MD directors’ responses was similar to those of PT and RN, with only 1 of 4 (25%) 
reporting that these two concepts are the same. Furthermore, all PT directors believe that 
teaching students how to prescribe exercise to clinical populations (defined in the survey 
as individuals living with chronic conditions) be mandatory. The varied RN opinions 
substantially differ from PT responses as shown in Figure 1. 
 
Figure 1: Program directors’ belief that teaching students how to prescribe exercise to 
clinical populations should be mandatory. PT: physiotherapy; RN: nursing. 
The how of exercise prescription. Questions 3, 4, and 5 (Table 1) comprise the 
how of exercise prescription section of the survey. All PT directors strongly agree, while 
the majority (90%) of RN directors disagree or strongly disagree that their students are 
taught how to design an exercise program for individuals living with medical conditions. 
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Also, all PT directors strongly agree, while the majority (90%) of RN directors disagree 
or strongly disagree that as part of their curriculum students are taught how to prescribe 
exercise(s) using specific criteria such as frequency, intensity, repetitions, etc. In 
addition, all PT and only 10% of RN directors agree or strongly agree that as part of their 
curriculum students are taught how to implement an exercise program.  
Similar to RN, MD directors’ responses show similar trends where they 
predominantly disagree or strongly disagree (90%) that their students are taught how to 
design an exercise program for individuals living with medical conditions, and all felt 
that their students would not know how to implement an exercise program or how to 
prescribe appropriate exercise(s) by using specific criteria.  
Safety and exercise prescription. Questions 6, 7, and 8 respectively, informed the 
safety and exercise prescription category of the survey (Table 1). All PT directors 
strongly agree that students are taught established exercise precautions and 
contraindications, while 50% of RN directors agree and 50% disagree with this statement. 
In addition to teaching students about established exercise precautions and 
contraindications, 100% of PT directors strongly agree, while 60% of RN directors agree 
or strongly agree that their students are taught what to monitor to ensure safety during 
exercise. For MDs, response trends suggest that medical students are not taught about 
exercise precautions, but some suggest teaching students about exercise 
contraindications. There is also a divide on whether exercise prescription should be 
mandatory in medical schools’ curriculum (see frequency details in Appendix B). 
Exercise advice, benefits, and physiological effects. Survey questions 10, and 11 
informed the exercise advice, benefits, and physiological effects category. Most PT 
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directors (90%) strongly agree and 80% of RN directors agree or strongly agree that their 
students are taught how to advise patients about the benefits of exercise. Ten percent of 
PT directors did not answer this question, while 10% of RN directors disagree that their 
students are taught how to provide advice on the benefits of exercise. Furthermore, a 
majority (60%) of RN directors agree and 90% of PT directors strongly agree that they 
offer lectures dedicated to the physiological effects of exercise on chronic disease. Trends 
from MD responses are similar to those of PT and RN (see frequency details in Appendix 
B).  
Current exercise prescription curriculum. Questions 13, 14, and 15 informed the 
current exercise prescription curriculum category in the questionnaire. Majority (90%) of 
PT directors agree or strongly agree that there is at least one course dedicated to teaching 
students about the benefits of exercise, while 80% of RN directors disagree or strongly 
disagree that they offer such a course(s). Another 70% of PT directors agree and 60% of 
RN directors disagree that exercise prescription is integrated within mandatory courses. 
Responses from MD directors show similar trends to PT (Appendix B). 
When asked whether the curriculum provides a sufficient amount of exercise 
instruction, 60% of PT directors strongly agree that they did, while another 40% of them 
did not provide an answer. Forty percent of RN directors disagree, while another 40% do 
not know, and only 20% agree or strongly agree that their students receive sufficient 
amount of exercise instruction. The MD directors were divided here: 50% disagree or 
strongly disagree that they have sufficient instruction regarding exercise (Appendix B).  
Future curriculum plans. When asked if there is a plan to provide a course on 
exercise prescription in five years (Question 16-Table 1), 80% of PT participants report 
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already having such a course, while 10% will, and 10% do not have plans to include a 
course on exercise prescription. Some of the comments indicate that exercise prescription 
is an integral component of all courses, or that it is integrated throughout the curriculum 
rather than presented in a single course: 1) “topics are integrated across multiple courses 
and both years of training, so our program is not conducive to a specific course”; 2) “all 
our courses have exercise prescription as an integral component”; 3) “we have this 
course, but are planning to increase it to 2 courses”.  
On the other hand, 30% of RN directors plan to have an exercise prescription 
course, while 30% do not know and another 30% have no plans of including such a 
course within their curriculum over the next five years. None report already having such a 
course, although one comment reflects that exercise is integrated within the curriculum as 
a healthy living component within the broader context of health promotion, as shown by 
the following quote: “We are reviewing our curriculum and plan to enhance our healthy 
living components, including self-care for our students as future health care 
professionals. We advocate a collaborative rather than prescriptive approach to healthy 
living, for self and working with clients, that considers the complexity of social 
determinants of health and focuses on empowering, respectful health promotion practice. 
These components are and will be integrated throughout the curriculum, rather than 
presented in a single course”. 
An MD director commented that exercise is integrated throughout the curriculum, 
but recognized that there is limited coverage of this topic, which they plan to address by 
including “more emphasis on the practical application of knowledge, including exercise 
prescription”. Another MD director acknowledged the benefit of exercise, but expressed 
 
 
19 
that medical students should not be experts in the field, as evident from the following 
quote: “The basic rationale for not including much specific exercise prescription 
instruction in the curriculum is that an MD, although cognizant of the beneficial effects 
of exercise, and aware of when exercise would be beneficial or not; cannot expect to also 
become a kinesiologist/exercise scientist/physiotherapist while they are becoming an MD. 
At some point, their knowledge of complementary therapies has to reach a limit so as not 
to compromise the completeness of their basic medical education within the 4 years of the 
program. Agreed on the importance of exercise, but not that med students should be the 
experts in this field.”  
Exercise prescription and chronic disease(s). Question 12 was posed to 
determine what chronic disease(s) are discussed in relation to exercise prescription. 
Ninety percent of PT directors report teaching students how to prescribe exercises to 
individuals living with: chronic obstructive pulmonary disease (COPD), type 2 diabetes 
mellitus (T2DM), stroke (CVA), coronary artery disease (CAD), while 80% address type 
1 diabetes mellitus (T1DM). Participants (30%) also provided “other” conditions 
including hypertension, multi-system impairments and/or individuals with comorbidities, 
while one PT director emphasized that there are “too many [chronic diseases] to list”. 
Some of the additional conditions that emerged in the PT curriculum included: obesity, 
cancer, renal disease, fibromyalgia, polio, post-polio, cerebral palsy, osteoarthritis, 
rheumatoid arthritis, muscular dystrophy and head injury. One quote summarized that the 
PT curriculum included education about “all major chronic conditions”.  
In comparison, 40% of RN directors report teaching students about exercise and 
individuals with “multi-system impairment”, while 30% cover CAD, T2DM, COPD, and 
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20% discuss CVA and T1DM. Additionally one participant explained: “We work within 
a broader focus on healthy living and emphasize collaborating with clients, rather than 
prescribing to them. Chronic disease management, including lifestyle strategies, are 
included in the curriculum.”  
Finally, one of the MD directors suggested that students are taught about exercises 
and a “wide variety of MSK disorders” while another one stated that their curriculum 
covered “individuals living with chronic conditions.”  
Utilization of specific exercise guidelines. Question 9 was posed in the survey to 
determine whether established exercise guidelines are utilized when educating students 
on exercise recommendations (Table 1). A majority (90%) of PT directors report using 
the following: American College of Sports Medicine (ACSM) and Canadian Physical 
Activity Guidelines (CPAG), while another 80% indicate using Canadian Society for 
Exercise Physiology (CSEP). Additionally, 30% of PT directors report using Canadian 
Diabetes Association guidelines and another 30% report relying on “current evidence-
based literature”. “Other” guidelines that were highlighted by PT directors include: 1) 
“Position statements [from] specific professional groups such as “ATS statement for 
pulmonary rehab, Canadian Diabetes Association for diabetes management”; 2) “YMCA 
protocol, stroke specific guidelines (i.e., Canadian Stroke Best Practice Guidelines)” 
3)“… Canadian Association of Cardiovascular Prevention and Rehabilitation, 
Osteoporosis Canada (BoneFit)”  
Several (40%) RN directors report not using any established guidelines, while 
30% utilize CPAG. Additionally, 10% report using ACSM and CSEP, while another 10% 
indicate not knowing whether any guidelines are used to teach exercise specific 
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recommendations to nursing students. Finally, three MD directors report using CPAG, 
two use both ACSM and CSEP, while one reports not using any established guidelines  
Phase 2: ORPAS document review. A document review of ORPAS information 
on undergraduate programs focusing on exercise education was completed for the year 
2008-2012 (Table 3). A majority (56 to 62%) of the students accepted into one of four 
Ontario PT programs surveyed had an exercise-based undergraduate education (i.e., 
human kinetics/kinesiology, exercise science, physical & health education, and 
physio/physical therapy).  
Table 3: Percentage of students with exercise-focused undergraduate degrees accepted 
into one of the potential four Ontario-based physiotherapy programs. 
Undergraduate Education  2008 2009 2010 2011 2012 
Human Kinetics/Kinesiology 55.4% 53.7% 49.5% 53% 52.1% 
Exercise Science 0.7% 1.5% 1.5% 1.4% 1.4% 
Physical & Health Education  3.2% 5.2% 5.1% 1.8% 2.8% 
Physio/Physical Therapy  0% 1.5% 0.4% 0.7% 0.7% 
Other Non-Exercise Based Education 40.7% 38.2% 43.6% 43.1% 42.9% 
Total Exercise-Based Education  59.4% 61.9% 56.4% 56.9% 57.1% 
 
Discussion 
This study set out to compare physiotherapy (PT), nursing (RN) and medical 
(MD) program curricula to determine whose students may be best prepared to prescribe 
exercise within primary care for the purpose of chronic disease prevention and 
management. There was a notable difference in response rate (Table 2) between PTs 
(n=10; 100%), RNs (n=10; 59%), and MDs (n=4; 33%). This difference in response rate 
might reflect poor timing of the survey (i.e., distributed during the summer term). In 
addition, the survey might have had greater buy-in from RNs and MDs if a professional 
from their area of practice administered it, rather than a graduate student pursuing a 
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combined PT/PhD degree. Furthermore, the response rate may also indicate competing 
research priorities amongst RN and MD program directors, which could have limited 
their participation. Finally, the response rate from RNs and MDs may indicate a generally 
lower level of interest in research regarding exercise prescription for chronic disease 
prevention and management. Despite the varied response rate, informative findings 
emerged that are further elaborated in this discussion section.  
We determined that the three participating groups had an overall statistically 
significant difference in the way that they responded to the survey questions. Thus, we 
found an overall trend that exposure to exercise prescription within their curricula varied. 
The first section of the survey assessed beliefs about exercise prescription. Findings show 
that PT and RN program directors believe exercise prescription and general advice for 
people to be active is not the same thing, with similar trends noted from the limited 
number of MD responses. Recognizing the distinction between exercise advice and 
exercise prescription is imperative, since primary care providers should be able to provide 
general advice by discussing the health benefits associated with exercise and also 
encourage someone to be/become physically active. However, once a person is prepared 
to increase exercise levels, they may require additional expertise in order to commence a 
safe exercise program. Thus, advice initially offered by a healthcare professional for 
someone to increase his or her activity levels becomes insufficient, because at that point 
knowledge on how to prescribe an exercise program becomes crucial.  
In order to guide a person on how to exercise, a question was posed whether 
teaching students how to prescribe exercises should be mandatory. While the findings 
(Figure 1) show that all PT directors strongly believe that such instruction should be 
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mandatory, the majority of RN’s did not know or disagreed with this statement. This 
difference might be partially explained in how RN’s perceive exercise as a lifestyle 
component within the broader context of health promotion, as supported by one of the 
RN participants who stated that: “we work within a broader focus on healthy living and 
emphasize collaborating with clients, rather than prescribing to them. Chronic disease 
management, including lifestyle strategies, are included in the curriculum”. 
 This comment raises an interesting perspective that this RN director may have on 
exercise prescription, where the word prescription is perceived as something that’s done 
to the client, rather than created with the client at the center of the process. From this RN 
director’s perspective, prescription might be viewed as a hierarchical or top-down 
approach to interacting with clients, rather than a collaborative endeavor. This 
perspective may be closely linked to the perception of how medication is prescribed. 
Medical doctors have the knowledge and training to advise clients on appropriate 
pharmacological interventions. Although this process could be viewed as a one-way 
interaction, where the physician prescribes medication(s) to the patient, ideally, sufficient 
education about the risks, benefits, and alternatives is discussed with the client and/or 
their substitute decision maker. Also, during this interaction the client’s concerns and 
questions should be addressed—the essence of client-centered care.16 As a result, the 
ultimate decision to take the medication is left to the now well-informed client or 
substitute decision maker.  
 Individuals seeking advice from physicians trust that the advice and in turn the 
medication prescription is correct, as it is provided by a professional with appropriate and 
extensive training in that area of practice. An exercise prescription ought to be considered 
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in a similar way, where the individual who would benefit from this intervention would 
receive advice and a specific prescription from the most appropriately trained and 
qualified healthcare provider. That being said, an exercise prescription ought to be 
recognized as an iterative process where the individual who would benefit from the 
prescription is fully integrated and plays a central role throughout the process.  
The how of exercise prescription. Three questions from the survey aimed to 
determine the how of exercise prescription. Questions from this section asked whether 
students are taught how to: 1) design an exercise program; 2) prescribe exercise using 
specific criteria such as frequency, intensity, duration, etc.; and 3) implement an exercise 
program. While all PT directors reported that their students receive this training, the 
majority of RN directors suggest this content is not included within the nursing 
curriculum, with MD directors showing similar trends to RN directors’ responses.  
These findings suggest that although RN and PT directors recognize that advice 
and giving a specific exercise prescription is not the same, only PT students are taught 
how to prescribe an exercise program. Also, despite medical schools being encouraged to 
incorporate exercise into their curriculum9,13,14 the four MD directors from three different 
Canadian provinces suggest that their students are not provided with specific education 
on how to develop, prescribe, or implement a specific exercise program.  
Exercise curriculum content. Based on the findings summarized within the 
following categories: 1) safety and exercise prescription; 2) exercise advice, benefits and 
physiological effects; 3) and current exercise curriculum, it is evident that all three 
primary care providers are able to discuss the physiological effects of exercise on various 
chronic disease(s) and advise individuals on the benefits of exercise, but the PT curricula 
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is the only one that incorporates exercise within mandatory courses. This indicates that 
physicians, nurses, and physiotherapists could all play an important role as advisors to 
facilitate exercise participation by educating clients about the benefits of exercise. 
However, once a person is prepared to start exercising, PTs would be the only clinicians 
formally trained to design, implement, and modify an exercise program to ensure it is 
appropriate and safe. 
Study findings also suggest that current PT programs are the only ones that 
provide sufficient and extensive exercise content to their students as part of their 
mandatory curricula. On the other hand, based on RN directors’ feedback, it is evident 
that curricula changes would be required for their students to receive sufficient exercise 
instruction. Previous researchers have also called for change within medical programs to 
ensure future physicians are better informed on how to prescribe exercise to their 
clients.13,14,17 However, given the arduous process of changing a curriculum, along with 
barriers such as lack of time and limited space for exercise implementation within 
physicians’ practice context, resources and energy may be better directed in improving 
effective exercise prescription by relying on already trained and available primary care 
providers for this task.  
Based on this study, it is apparent that the Canadian primary care system has 
qualified healthcare professionals—physiotherapists—with extensive knowledge on 
exercise whose fundamental component of daily practice includes exercise prescription.18 
In addition to the exercise curriculum offered during the PT program, the ORPAS 
document review from 2008-2012 demonstrates that close to 60% of students pursuing 
PT have exercise-based undergraduate educations (Table 3), meaning that prior to 
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commencing graduate studies, the majority of students pursuing a degree in physical 
therapy have a strong exercise science foundation that they can further develop during 
their professional clinical training. Recognizing that PTs are extensively trained to 
prevent and manage various injuries that may result from exercise participation further 
supports PTs as potential leaders for exercise prescription within primary care. 
Findings from the survey also demonstrate that PT students are exposed to 
established evidence-based exercise guidelines and are trained on how to prescribe 
exercises when working with individuals who have numerous chronic disease(s), 
including complex and/or multi-system impairments. Additionally, physiotherapists work 
within environments conducive to exercise implementation with equipment and personnel 
to ensure monitoring, progression, and maintenance of an appropriate exercise program.18 
From the three primary care providers assessed in this study, it is concluded that 
physiotherapists are best prepared to prescribe exercise(s) to aid chronic disease 
prevention and management within the primary care context. 
Previous researchers19 have shown elderly people and those with chronic disease 
often rely on publicly funded PT services in the community. However, only 6.4 full-time 
PT’s were employed by Ontario’s 54 community health centers in 2004, while family 
health teams did not have any physiotherapy members on their staff in 2011. 20 
Additionally, physicians have highlighted that the cost of private care results in fewer 
referrals to PT services, despite being aware of the benefits the clients could receive from 
timely PT interventions.19 Limited inclusion of PT services within primary care increases 
results in poor access to physiotherapy for those that often needed it most (i.e., elderly 
and individuals with chronic disease). Yet PTs are well prepared to tackle the challenge 
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of incorporating effective exercise prescription within primary care, thus addressing a key 
corner stone of chronic disease prevention and management.19 Similarly to previous 
research,20 findings from this study support policy implications to increase funding for 
PTs in primary care to enable access to appropriate interventions for all. 
Limitations and future research directions. Future researchers may want to 
explore formal exercise education of additional primary care or alternative healthcare 
providers, chiropractors, registered kinesiologists, etc. Given the recent regulation of 
kinesiologists in Ontario and their expanding autonomy in clinical practice with potential 
expansion into primary care, it would be interesting to determine what role they might 
play with respect to exercise prescription with individuals who are at risk or have chronic 
disease(s). Kinesiologists were excluded from this study because they recently (in 2013) 
became a regulated profession in Ontario and their role in the primary care context is yet 
to fully develop. For example, at the time of this study they were not providers that would 
receive referrals from community care access centers, who are integral to connecting 
appropriate healthcare providers with individuals who present with complex healthcare 
needs in the community, such as those living with chronic disease(s). However, their 
expanding role and evolution in practice will be important to study in the future.  
Also, findings are not representative of every professional program offered in 
Canada and as such there are limitations in generalizability of the findings. Additionally, 
despite reported trends from several MD directors who participated from three different 
provinces across Canada, caution must be taken in interpreting findings with respect to 
medical schools due to the low response rate.  
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The survey takes into account one perspective (i.e., program directors) and is thus 
at risk of bias to that participant. Additionally, student perspectives were not assessed in 
this study, but are worth exploring in the future, as it would be valuable to determine 
whether students and/or recent graduates feel that the exercise curriculum offered in their 
respective professional programs is sufficient and if it translates well when prescribing 
exercise in clinical practice. 
Finally, RNs and PTs from various practice contexts should also be evaluated to 
determine their confidence in prescribing exercise with individuals presenting with 
chronic disease(s). Although, previous researchers21 have evaluated family physicians’ 
confidence with exercise prescription, to our knowledge RN’s and PT’s have not been 
included in such evaluation.  
Conclusion 
 Several novel conclusions emerge from this study. First, arduous curriculum 
changes in medical or nursing schools to include exercise prescription may be an 
inefficient use of resources, given that physiotherapists are already primary care 
providers with extensive formal exercise education. Second, physicians and nurses should 
advocate for exercise and refer individuals to PTs for detailed exercise prescription to 
address chronic disease prevention and management. Third, policy changes are needed to 
ensure physiotherapists are integral members of chronic disease prevention and 
management teams, such as family health teams, to enable exercise prescription benefits 
for all. Therefore, we propose that physiotherapists ought to lead the exercise prescription 
movement in primary care for the purpose of chronic disease prevention and 
management, with MDs and RNs participating as exercise advisors or facilitators.  
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Chapter 3: Exercise Prescription Considerations for Individuals with Multiple 
Chronic Diseases: Systematic Review 
 
Introduction  
In Canada 41% of patients have at least one chronic disease while 6% have three 
or more chronic diseases.1 According to the World Health Organization,2 chronic diseases 
are the leading causes of death worldwide, while in Canada 67% of deaths each year are 
due to cancer, diabetes, respiratory, and cardiovascular conditions.3 Overall, hypertension 
is the most prevalent chronic disease followed by depression, osteoarthritis, diabetes 
mellitus, asthma, chronic obstructive pulmonary disease (COPD), and finally coronary 
artery disease (CAD).1 Exercise has been shown to improve chronic disease management 
and function, decrease pain, and reduce morbidity and mortality.3-8 To take advantage of 
these benefits, exercise guidelines for the general population, as well as for individuals 
with specific chronic diseases have been standardized. The aim of this systematic review 
was to determine specific overlapping physiological and subjective markers that could be 
used by clinicians to determine safe exercise prescription for individuals with multiple 
chronic diseases. For the purposes of this review, physiological markers are those that can 
be objectively measured by a clinician indicating a physiological change in the body, 
while subjective markers are reported by the individual before, during or after exercise. In 
this way, a personalized guideline could be determined for people with multi-system 
involvement in order for clinicians to provide objective and systematic exercise 
prescription for these individuals. 
           Numerous exercise guidelines4,6-14 have repeatedly highlighted the importance of 
tailoring exercise on an individual basis to ensure a safe and appropriate activity program 
is implemented. However, none have provided specifics on how this could be done 
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effectively, taking into account the complexity of health conditions experienced by 
individuals living with chronic diseases. The major recommendation from most 
guidelines is to see your “physician or healthcare provider”, which assumes that your 
specific healthcare provider has the appropriate knowledge and training to develop and 
implement an individually tailored exercise program. However, as discussed in chapter 2 
of this thesis lack of time and limited knowledge have repeatedly emerged from the 
literature as barriers for physicians to prescribe exercise to individuals.15-18 Given that 
current exercise guidelines are designed for the general/healthy population or geared 
towards those living with a single chronic disease, there is limited guidance to ensure 
safety with exercise prescription for individuals living with more than a single disease. 
           Therefore, despite the availability of general exercise guidelines for individuals 
with one chronic disease, people with multiple conditions tend to receive exercise 
prescription based on non-objective measures and clinical reasoning as opposed to 
standardized protocols.5 Physiotherapists (PTs) commonly develop exercise protocols for 
clinical populations, which often include individuals living with chronic diseases. 
Currently, they acquire medical histories from patients and then develop individualized 
exercise programs in the absence of disease-specific contraindications. For instance, the 
recommended exercise guidelines for patients with type 2 diabetes (T2DM) include 30 
minutes of aerobic activity, 5 times per week.6-8,10,13 Contraindications to exercise for 
patients with type 2 diabetes include severe autonomic neuropathy, severe peripheral 
neuropathy, and pre- or proliferative retinopathy.13 Similar exercise guidelines exist for 
patients with coronary artery disease (CAD) and chronic obstructive pulmonary disease 
(COPD), including recommendations of at least 150 minutes of aerobic exercise per week 
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for patients with CAD,9,11,12,14 and 30-60 minutes of aerobic exercise at least 3 times a 
week for patients with COPD.19,20 Contraindications to exercise for patients with CAD 
include unstable angina, uncontrolled arrhythmias, heart failure, stenotic/uncompensated 
valves, and hypertrophic obstructive cardiomyopathy.9,21 Current contraindications to 
exercise for patients with COPD consist of severe hypertension, hypoxemia with a drop 
of oxygen saturation below 85%, uncontrolled angina, or congestive heart failure.19 This 
review attempts to extrapolate key physiological markers from multiple systems in the 
body, based on leading chronic diseases, in order to begin addressing the how of 
individualized exercise prescription. If safe ranges of key physiological markers are 
identified from each system in the body, clinicians can then begin to have concrete 
markers they can monitor to ensure safe exercise programs are implemented on an 
individual basis. Also, this systems-based approach to exercise prescription might enable 
tailored programming for individuals with multiple chronic diseases. This is a worthwhile 
endeavour, given that over half of the population living with a chronic condition have 
more than one disease.22 
For this review, three of the seven most common chronic diseases in Canada were 
chosen for investigation, from three different body systems: coronary artery disease 
(cardiovascular system), chronic obstructive pulmonary disease (respiratory system), and 
type 2 diabetes (endocrine system). These three diseases were chosen in the attempt to 
identify disease-specific physiological markers that could indicate a contraindication to 
exercise. This systems-based approach can be further developed in the future by 
extrapolating key markers from many other diseases to enable a more encompassing 
system for exercise prescription 
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Methods 
Studies were identified from eight electronic databases: CINAHL, PubMed, 
MEDLINE, EMBASE, SCOPUS, Cochrane, AMED and Pedro. These databases 
generated MESH terms based on the following keywords: coronary artery disease (CAD), 
chronic obstructive pulmonary disease (COPD), diabetes mellitus/diabetes, 
contraindication, adverse, risk, treatment, testing, training, physical activity, exercise, 
guideline, recommendation. These search terms were entered into the databases using an 
appropriate combination of “OR” and “AND” (see Appendix D for a search history 
sample). In order for the articles to be included in this systematic review, the inclusion 
and exclusion criteria (Table 4) needed to be satisfied: 
Table 4: List of inclusion and exclusion criteria  
 
Inclusion Criteria  Exclusion Criteria  
· Participants must be over the age of 18 
· Paper must include the disease searched 
· Must be human subjects 
· Either aerobic or strengthening exercise was 
administered to the patient 
· Must have an appropriate physiological or 
biological outcome measure 
· Must be English 
· Must be a guideline, systematic review, meta-
analysis or randomized control trial 
· Combined chronic conditions (e.g., Cancer and 
Cerebrovascular Accidents) 
 Goal: extrapolate key physiological markers 
per system; combining systems at onset 
prevents achievement of goal.  
· Outcomes of disease processes (e.g., MI and Heart 
Failure) 
· Neuromuscular, Neurological, Gastrointestinal, 
Psychological, Nephrological and Excretory 
Conditions: 
 Not in the upper most prevalent disease 
states 
· Acute/non-chronic disease states 
 
The aforementioned inclusion and exclusion criteria were developed in order to 
obtain the most recent (last 10 years), scientifically rigorous (e.g., RCTs) evidence. 
Various review articles, commentaries, and case-studies that did not satisfy the inclusion 
criteria were used to inform the introduction and the discussion sections of this paper. 
The search was conducted from June 1, 2013 to December 1, 2013. The objective of this 
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review was to identify the effects of exercise on key physiological markers that could 
result in death if not maintained in their safe range.  
Both COPD and T2DM are the leading causes of death in chronic respiratory and 
endocrine disease states respectively. T2DM was chosen over type 1 diabetes mellitus 
(T1DM), because it is more prevalent and it can be controlled with exercise and diet, 
whereas T1DM must be controlled with insulin injections. The leading cause of death for 
the cardiovascular system is myocardial infarction, which was not included as it is an 
outcome of other disease states not a chronic disease in and of itself. As such, CAD—a 
chronic disease where the major blood vessels (i.e., arteries) that supply the heart with 
blood, oxygen, and nutrients become damaged—was selected for the cardiovascular 
system. With CAD, damage to the arteries often results from deposits, known as plaques, 
which lead to narrowing and/or inflammation of these vessels, thus impeding proper 
blood flow to the heart. Some of the common consequence of CAD can include chest 
pain (angina), shortness of breath, and a heart attack (death of cardiac tissue).  
Outcome Measures. Outcome measures in this review include: 1) physiological 
markers such as heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure 
(DBP), respiratory rate (RR), peripheral capillary oxygen saturation (SpO2) and blood 
glucose, and 2) subjective markers such as the rate of perceived exertion (RPE) and the 
Borg Scale reviewed for each disease state. These markers were chosen as a way to 
monitor physiological and subjective changes that can occur during exercise. 
Data Collection and Analysis. After keyword searches were completed, all 
duplicate articles were eliminated using RefWorks software. Next, article titles and 
abstracts were screened (JK-CAD, DB-COPD, AVV-T2DM, FM-T2DM) based on the 
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inclusion and exclusion criteria. Then, two authors independently reviewed full-text 
articles, and selected papers were compared based on the inclusion and exclusion criteria. 
Reviewers (JK, AVV) analyzed all COPD and CAD articles and reviewers (DB, FM) 
analyzed all diabetes articles. Discrepancies between articles selections were decided or 
clarified by a third party (JK, DB). Finally, remaining articles were then reviewed for 
data extraction. Furthermore, NH was instrumental throughout the entire research 
process. Specifically, NH supervised the team, developed the research question, 
collaborated with the team to establish the search strategy, created a data extraction 
template, and provided extensive feedback to ensure the literature review was finalized 
and published within a peer reviewed journal.  
See Figure 2 for a detailed overview of the article selection process. The 
following data were extracted from the selected studies: 1) characteristics of the exercise 
interventions, including: type, frequency, intensity, and duration; 2) characteristics of the 
outcomes: physiological or subjective outcome measures.  
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Figure 2: Article Selection Process. CAD: coronary artery disease; COPD: chronic 
obstructive pulmonary disease; T2DM: type 2 diabetes mellitus; RCT: randomized 
control trial; MA: meta-analysis.  
Results 
 Based on the review of the literature, it is recommended that individuals living 
with chronic diseases should engage in aerobic, resistive or a combination of both of 
these types of exercises. Specific exercise recommendations, as well as contraindications 
and/or precautions are summarized below within appropriate tables. 
Table 5: Exercise recommendations for aerobic training (AT) 
 Frequency Intensity Time Type 
T2DM Every day  10,000 steps AT – walking23 
  150 minutes per week AT24 
5 days per week  30 minutes per day AT25 
 1000 Kcal per week  AT26 
Records Identified Through 
Database Search 
n = 4214 
Number of Records 
Screened 
n = 2954 
Records Excluded Based 
on Title and Abstract 
n = 2542 
Number of Full Texts 
Screened 
n = 412 
Number of Studies 
Included for Qualitative 
Synthesis (See Appendix 
H) 
CAD n = 8 
COPD n = 10 
T2DM n = 21 
 
Total n = 39   
Records Excluded Based on Inclusion Criteria 
(See Appendix H) 
* Not an RCT, MA or Guideline n = 56 
* No Exercise Administered n = 121 
* No Outcome Measure n = 20 
* Not an Adult Population n = 4 
* Not Disease Searched n = 168 
* Not English n = 2 
* Not Range of Years Searched n = 1 
* Not Available = 1 
 
Total n = 373  
Duplicates 
n = 1260 
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 Recommendations for aerobic training (AT) (see Table 5) have emerged 
throughout the research for individuals with chronic diseases. For individuals with 
T2DM, multiple studies have shown that accumulating 150 minutes a week of moderate 
(40% to 60% VO2 maximum) to vigorous (60 to 90% VO2 maximum) physical activity is 
recommended.7,8,24,25,28,30 For individuals with T2DM, 30 to 40 minutes of cycling per 
day, 5 times per week, at an intensity of 75% of VO2 maximum is recommended.
29 In 
2011, Araiza and colleagues23 found that it is safe for an individual with T2DM to walk 
10,000 steps per day monitored using a pedometer.  
Recommendations for individuals with CAD vary between researchers. Briffa and 
colleagues found that aerobic exercise may be performed most days of the week for 30 
minutes at a moderate intensity.9 Similarly Pavy and colleagues recommend aerobic 
exercise 3 to 6 days a week for 30 to 60 minutes, while maintaining a rate of perceived 
exertion (RPE) between 12 and 14.11 In a 2011 systematic review, Cornish and colleagues 
  150 minutes per week AT – treadmill7 
5 days per week  20 to 30 minutes AT- treadmill8 
4 days per week moderate 3 miles AT27 
3 days a week moderate 50 minutes AT28 
5 days a week 75% VO2 max 30 to 40 minutes AT – cycling29 
3 to 4 days a week 
 
50% to 70% VO2 
max 
150 minutes per week 
 
AT30 
 
CAD Most to all days of 
the week 
Moderate 30 minutes per day AT9 
3 to 6 days per 
week 
12 to 14 Rating of 
Perceived Exertion 
30 to 60 minutes AT11 
2 to 5 days per 
week 
70% to 95% VO2max 30 to 60 minutes AT31 
COPD  
 
60% to 80% of 
symptom onset 
20 minutes AT32 
4 days per week 7 to 34 Watts  AT – cycling33 
2 to 3 days per 
week 
75% to 80% peak 
workload, 40 Watts 
2 to 15 minutes 
 
AT – cycling34 
 
2 to 3 days per 
week 
80% maximum 
workload 
30 to 60 minutes AT20 
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found that individuals with CAD are able to perform aerobic exercise 2 to 5 days per 
week for 30 to 60 minutes, at an intensity of 70 to 95% VO2 maximum.
31  
Furthermore, research has determined that individuals with COPD are also able to 
safely participate in aerobic training (AT). Sharma and Singh20 found that those with 
COPD are able to participate in AT 2 to 3 times per week for 30 to 60 minutes, working 
towards a goal of 80% workload cycling or on a treadmill. These results were similar to 
those of Nonoyama and colleagues,34 who recommend 2 to 3 sessions per week of 
cycling for 15 minutes, at 75% to 80% peak workload while Corbridge and colleagues32 
recommend 20 minutes at an intensity that is 60% to 80% of symptom onset (e.g., 
dyspnea and fatigue). If the individual with COPD prefers cycling, it is safe to cycle at an 
intensity of 7 to 34 watts, performed 4 times a week.33 
Table 6: Exercise recommendations for resistance training (RT).  
 Frequency Intensity Time Type 
T2DM 3 days per week  10 repetitions RT35 
 
CAD 2 to 3 days per week 30% to 60% 
maximum 
voluntary 
contraction 
 
1 to 2 sets, 5 to 15 
repetitions 
RT21 
 12 to 14 Rating 
of perceived 
exertion 
8 exercises, 1 set, 
10 repetition 
 
RT36 
COPD  50% one 
repetition 
maximum 
3 sets, 10 
repetitions, 
progressing to 3 
sets of 15 
repetitions 
RT37 
 
 Compared to research completed on AT or a combination of AT and resistive 
training (RT) for individuals with chronic diseases, few research studies have been 
conducted looking at the effects of RT alone for chronic disease (see Table 6). For 
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individuals with T2DM it is recommended RT occur 3 days per week, completing 10 
repetitions per major muscle group.35 
 For individuals with CAD, Bjarnason-Wehrens and colleagues21 recommend 1 to 
2 sets with 5 to 15 repetitions per set at an intensity of 30% to 60% maximum voluntary 
contraction. DeJong and colleagues36 recommend RT at an intensity of 12 to 14 RPE, 
completing 1 set with 10 repetitions of each of the 8 exercises (i.e,. leg press, latissimus 
dorsi pull down, military press, lateral row, chest press, triceps press, biceps curl, and leg 
extension).  
 Recommendations for RT for those with COPD are limited to one study. Costi 
and colleagues37 recommend performing upper extremity exercises (e.g., shoulder 
abduction, deltoid lift in the scapular plane, behind head triceps press, bicep curls at 90 
degrees shoulder abduction and bicep curls) at an intensity of 50% of one repetition 
maximum weight, starting at 3 sets of 10 repetitions. When the individual rates the 
difficulty as 3 on the Borg scale, then the repetitions are increased to 12, then again to 15. 
Subsequently, once an individual reaches level 3 on the Borg RPE 0-10 scale while 
completing 3 sets of 15 repetitions, resistance is increased by 500 grams and the exercise 
cycle is repeated.  
Table 7: Exercise recommendations for combined aerobic and resistance training. AT: 
aerobic training; RT: resistance training.  
 Frequency Intensity Time Type 
T2DM  AT – 55% to 70% VO2 
max 
RT- 60% one repetition 
maximum 
 AT and RT38 
AT – 3 days per week 
RT- 2 days per week 
AT – 40% to 60% VO2 
max 
RT – 50% to 80% one 
repetition maximum 
AT – 150 minutes per 
week 
AT and RT6 
 AT – 60% to 85% VO2 AT – 15 to 75 minutes AT and RT39 
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max or maximum heart 
rate 
RT – 60% to 80% one 
repetition maximum 
per day 
3 days per week AT – moderate or vigorous 
RT – weight should not be 
able to be lifted more than 
8 to 10 times 
AT – 150 minutes per 
week 
RT – 3 sets, 8 to 10 
repetitions targeting all 
major muscle groups 
AT and RT40 
3 days per week AT – 40% to 60% VO2 
max or 50% to 70% 
maximum heart rate 
RT – moderate (50% to 
74% one repetition 
maximum) to high (75% or 
higher of one repetition 
maximum) 
AT – 150 minutes per 
week 
RT – 1 to 3 sets, 8 to 15 
repetitions 
AT and RT13 
2 days per weeks AT – 50% to 79% 
maximum heart rate 
RT – 30% to 50% one 
repetition maximum 
RT – 1 set, 8 to 10 
repetitions 
AT and RT41 
3 days per week AT – 65% to 85% heart 
rate reserve 
 
AT – 40 to 60 minutes 
RT – 6 to 8 repetitions, 8 
different muscle groups 
AT and RT42 
5 days per week AT - 40% to 70% VO2 
max 
RT - 50% to 74% one 
repetition maximum 
30 to 90 minutes per day AT and RT43 
3 to 5 days per week AT – 40% to 80% heart 
rate reserve 
RT – moderate to high  
AT – 150 minutes per 
week 
RT – 8 to 12 repetitions 
AT and RT44 
AT – 3 days per week 
RT – 2 days per week 
AT – 40% to 60% VO2 
max 
RT – moderate to vigorous 
AT – 150 minutes per 
week 
RT – 3 to 4 sets of 5 to 
10 exercises, 10 to 15 
repetitions 
AT and RT45 
CAD AT – 5 to 7 days per 
week 
RT – 2 to 3 days per 
week 
AT – 60% to 70% VO2 
max 
RT – 30% to 60% 
maximum voluntary 
contraction 
AT – 20 to 60 minutes 
per day 
RT – 1 to 3 sets, 8 to 12 
repetitions 
AT and RT12 
AT – 3 to 5 days per 
week 
RT – 2 to 3 days per 
week 
AT – 40% to 60% heart 
rate reserve 
RT – 30% to 70% one 
repetition maximum 
AT – 30 to 60 minutes 
per day 
 
AT and RT14 
COPD AT – 3 days per week 
RT – 2 to 3 days per 
week 
AT – 60% to 80% 
maximum workload 
RT – 50% to 80% one 
repetition maximum 
RT – 1 to 4 sets, 6 to 12 
repetitions 
AT and RT19 
1 to 7 days per week 50% maximum to 
maximum tolerable 
15 to 45 minutes per day AT and RT46 
 
 Research into chronic disease and RT has mostly occurred in combination with 
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AT (see Table 7). The majority of the studies investigating T2DM and a combination of 
AT and RT provided the same recommendations for AT as the studies looking at AT 
alone: 150 minutes of AT per week at moderate (40% to 60% VO2max) to vigorous 
intensity (60% to 90% VO2max).
6,13,40,44,45 Sigal and colleagues13 recommend that in 
addition to 150 minutes of AT per week, individuals with T2DM should perform RT for 
1 to 3 sets of 8 to 15 repetitions at moderate (50% to 74% one repetition maximum) to 
high (75% or higher one repetition maximum) intensity, 3 days per week, similar to the 
findings of Praet and Van Loon40 who recommend 3 sets of 8 to 10 repetitions at a weight 
that cannot be lifted more than 8 to 10 times, 3 days per week, targeting all major muscle 
groups. Weltman and colleagues44 suggest similar RT intensity (moderate to vigorous) 
and repetitions (8 to 12) but recommend RT 3 to 5 days per week in combination with 
AT. Whyte and colleagues45 recommend that in addition to regular AT, RT should 
include 3 to 4 sets of 10 to 15 repetitions at moderate to vigorous intensity, 2 days per 
week, while completing 5 to 10 exercises targeting major muscle groups. Colberg and 
colleagues6 recommend 5-10 RT exercises targeting major muscle groups, with 10 to 15 
repetitions per exercise completed at moderate to vigorous intensity, 2 days per week. 
They further recommend coupling RT with 150 minutes of AT per week.  
 Other recommendations for individuals with T2DM include AT at 55% to 70% 
VO2 maximum and RT at 60% of one repetition maximum,
38 which is similar to Hills and 
colleagues39 who recommend 15 to 75 minutes of AT per day at an intensity of 60% to 
85% VO2 maximum, and RT at 60% to 80% of one repetition maximum. Waryasz and 
McDermott43 recommend 30 to 90 minutes of AT per day for 5 days a week at an 
intensity of 40% to 70% VO2 maximum, and RT at 50% to 74% of one repetition 
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maximum, whereas Stewart and colleagues41 recommend AT 2 days per week, at an 
intensity of 50% to 79% maximum heart rate, and RT at 30% to 50% of one repetition 
maximum, with 1 set of 8 to 10 repetitions per exercise. In addition, Sukula and 
colleagues42 recommend AT and RT, 3 days per week. Specifically these authors 
recommend AT for 40 to 60 minutes at 65% to 85% of heart rate reserve and 6 to 8 
repetitions of RT for each of the 8 different exercises (e.g., seated leg press, knee 
extension, knee flexion, chest press, latissimus dorsi pull-down, overhead press, biceps 
curls, and triceps extension).  
 There are a limited number of studies providing RT and AT recommendations for 
people with CAD. Vanhees and colleagues14 recommend AT occurs 3 to 5 days per week 
for 30 to 60 minutes, at 40% to 60% of heart rate reserve and RT 2 to 3 days per week, at 
30% to 70% of one repetition maximum. Perez-Terzic and colleagues12 recommend AT 
occurs 5 to 7 days per week, for 20 to 60 minutes at 60% to 70% of VO2 maximum and 
RT 2 to 3 days per week, at 30% to 60% of a single maximum voluntary contraction, 
completing 1 to 3 sets of 8 to 12 repetitions.  
 Individuals with COPD can also benefit from a combination of AT and RT. Eves 
and Davidson19 recommend AT 3 days per week at 60% to 80% of maximum work load 
and RT 2 to 3 days per week, with 1 to 4 sets of 6 to 12 repetitions, at 50% to 80% of one 
repetition maximum. Finally, Gutpa and colleagues46 recommended AT and RT occur 1 
to 7 days per week, for 15 to 45 minutes per day, between 50% and maximum tolerable 
intensity. 
Table 8: Physiological marker recommendations. 
 Physiological Marker Safe Levels 
T2DM Blood Glucose (mg/dL) 100 to 3006,44 
70 to 30035 
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> 10013,30 
Blood Pressure (systolic/diastolic 
mmHg) 
< 260/15529 
Systolic < 200 mmHg if diabetic neuropathy present13 
CAD Blood Pressure (systolic/diastolic 
mmHg) 
<160/10021 
90 to 180/60 to 1009 
Systolic < 16011 
Heart Rate (beats per minute) 10 bpm below angina threshold11,12 
COPD Heart Rate (beats per minute) 131 to 14247 
79.7 to 93.937 
125 to 13034 
131 to 13448 
Blood Pressure (systolic/diastolic 
mmHg) 
195 to 210/93 to 10147 
187 to 197/87 to 9434 
Respiratory rate (breaths per minute) 20.9 to 21.937 
30 to 3434 
 
 When investigating physiological markers and exercise for individuals with 
chronic disease, there are multiple markers that should be monitored (see Table 8). Blood 
pressure is one that ought to be monitored in those living with T2DM, CAD, and COPD. 
For individuals with T2DM, Riddell and Burr29 recommend keeping systolic blood 
pressure less than 260 mmHg and diastolic blood pressure below 155 mmHg, while Sigal 
and colleagues13 recommend systolic blood pressure be kept below 200 mmHg for 
individuals with diabetic neuropathy. Blood glucose level is another marker that needs to 
be monitored with T2DM. The most common recommendation for blood glucose is to 
keep it between 100 and 300 mg/dL,6,44 or above 100mg/dL.13,30 Although Misra and 
colleagues recommend below 300 mg/dL for blood glucose levels, they were the only 
researchers to recommend that it is safe to exercise with blood glucose as low as 70 
mg/dL.35 
 Blood pressure also needs to be monitored in individuals with CAD. Bjarnason-
Weherns and colleagues21 recommend that systolic blood pressure be below 160 mmHg 
and diastolic blood pressure be below 100 mmHg, which is similar to the results of Pavy 
and colleagues11 (systolic blood pressure below 160 mmHg). Briffa and colleagues9 
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recommend systolic blood pressure be between 90 and 180 mmHg, with diastolic 
pressure between 60 and 100 mmHg. Individuals with CAD should also have their heart 
rates monitored and it is recommended that the heart rate should not go above 10 beats 
per minute below an individual’s angina threshold.11-12 
 Blood pressure is also imperative to monitor for individuals with COPD. Bradley 
and O’Neill47 recommend systolic blood pressure be between 195 and 210 mmHg and 
diastolic blood pressure be between 93 and 101 mmHg, which is similar to Nonoyama 
and colleagues34 who recommend a systolic blood pressure between 187 and 197 mmHg 
and a diastolic pressure between 87 and 94 mmHg. Several researchers34,37,47,48 have 
found safe ranges for heart rate for individuals with COPD. Nonoyama and colleagues34 
recommend 125 to 130 beats per minute, similar to both Bradley and O’Neill47 who 
recommend 131 to 142 beats per minute, and Zainuldin and colleagues48 (131 to 134 
beats per minute). Costi and colleagues37 have the lowest recommendation for heart rate 
at 79.7 to 93.9 beats per minute. Respiratory rate for individuals with COPD varies, with 
Costi and colleagues37 recommending between 20.9 and 21.9 breaths per minute, and 
Nonoyama and colleagues34 recommending 30 to 34 breaths per minute. 
Table 9: Contraindications and precautions to exercise. 
T2DM Contraindications Avoid exercise if blood glucose is greater than 300 mg/dl or less than 70 
mg/dl35 
If fasting blood glucose is greater than 15 mmol/L and ketones are elevated, 
no vigorous activity until glucose is under control29 
Severe autonomic neuropathy, severe peripheral neuropathy, proliferative 
retinopathy13 
If non- or proliferative retinopathy is present, no heavy weightlifting41 
No exercise if ketosis is present and if a person has retinopathy, vigorous RT 
and AT should be avoided.44 
Precaution Patient should be adequately hydrated if glucose levels are 300 mg/dl (16.7 
mmol/l). If taking insulin, carbohydrates should be ingested when blood 
glucose is less than 100 mg/dl (5.5mmol/l).6 
Temperature elevation of 4°F compared to the opposite foot may be a 
marker of inflammation and increased risk of ulceration.8 
If severe peripheral neuropathy, non-weight bearing activities like 
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swimming, bicycling or arm exercises should not be used.35 
Pay attention to peripheral artery disease or diabetic foot disease before 
starting exercise. Medication (insulin) needs to be adjusted before starting an 
exercise program.28 
Exercising at greater than 6 metabolic equivalents increases the probability 
of having a myocardial infarction. Vigorous activity needs to be supervised 
because of an increased risk for a cardiac event. For those at risk for a 
coronary event: warm up and cool down (10 minutes each) with 20 to 60 
minutes of activity at a lower intensity. Non-weight bearing exercises are 
suggested for high-risk individuals.29 
Moderate to severe hypertension (greater than 160/100) should be controlled 
before starting exercise.41 
Prior to exercising, individuals with diabetes taking insulin may need to 
reduce their insulin doses and consume carbohydrates to prevent 
hypoglycemia. Glucose should be ingested when blood glucose is less than 
100 mg/dl prior to exercising.30 
CAD Contraindications Unstable angina, uncontrolled arrhythmias, heart failure, 
stenotic/uncompensated valves, hypertrophic obstructive cardiomyopathy.21 
Terminate exercise with any of the following signs: dizziness, 
discomfort/pain in chest, leg ache that prohibits function, physical inability 
to continue, palpitations, fatigue, difficulty breathing, nausea, and excessive 
sweating.9 
Precautions Exercise should be stopped when rating of perceived exertion is 17 or 
higher.49 
Individual should be able to speak without breathlessness.11 
COPD Contraindications Severe hypertension, hypoxemia, uncontrolled angina or congestive heart 
failure.19 
Angina pectoris, recent myocardial infarction, severe pulmonary 
hypertension, congestive heart failure, unstable diabetes, inability to do 
exercise due to orthopaedic conditions, severe exercise-induced hypoxemia, 
not correctable with O2 supplementation, and unwilling to give consent.20 
Precautions Stop exercise if SpO2 drops below 88% or a sudden drop of 2-5% from 
average.50 
 
In terms of contraindications to exercise in individuals with multiple chronic 
diseases, each disease has a specific set of indicators that must be monitored to ensure 
safety for the individual (See Table 9). With T2DM, exercise is contraindicated and 
should not be performed in individuals with blood glucose level above 300 mg/dL or 
below 70 mg/dL.35,29 Exercise is also contraindicated for individuals with T2DM if they 
have ketosis,29,44 or severe autonomic or peripheral neuropathy.13 For individuals with 
retinopathy due to T2DM vigorous AT or RT is contraindicated.13,41,44 Individuals with 
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peripheral neuropathy may be able to safely perform non-weight bearing activities like 
swimming or cycling.35  
 Individuals with CAD should not exercise if they have unstable angina, 
uncontrolled arrhythmias, heart failure, stenosis or uncompensated valves, or 
hypertrophic obstructive cardiomyopathy.21 Exercise should be terminated if the 
individual starts to feel dizziness, discomfort or pain in chest, leg ache that prohibits 
function, physical inability to continue, palpitations, fatigue, difficulty breathing, nausea 
and/or excessive sweating.9  
 For those individuals with COPD, exercise is contraindicated if they have angina 
pectoris, recent myocardial infarction, severe pulmonary hypertension, congestive heart 
failure, inability to exercise due to an orthopaedic condition, severe exercise-induced 
hypoxemia not correctable with O2 supplementation, and/or are unwilling to give 
consent.19,20 
 Precautions to exercise should be considered before initiating and during 
participation in an exercise program (See Table 9). For individuals with T2DM on insulin 
therapy, to avoid a hypoglycemic event (a drop of blood sugar below 100 mg/dL) insulin 
may need to be adjusted6,30 or carbohydrates may need to be consumed before starting to 
exercise.6,28,30 Individuals with T2DM who exercise at an intensity of 6 metabolic 
equivalents (METS) are at an increased risk of myocardial infarction and need to be 
monitored closely when exercising. Riddell and Burr recommend that for those 
individuals at risk for a cardiac event (increased waist circumference, increased 
triglyceride levels, hypertension, advanced age, a history of smoking and a family history 
of CAD), a warm up and cool down of 10 minutes should be done and 20 to 60 minutes 
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of activity at a lower intensity.29 For individuals with uncontrolled hypertension (greater 
than 160mmHg SBP and/or 100mmHg DBP) blood pressure must be controlled before 
exercise can begin.41 Marwick and colleagues recommend that if there is a temperature 
elevation of 4°F in an individual’s foot when compared to the other, it may be a marker 
of inflammation and therefore the individual is at increased risk of ulceration.8  
 Individuals with CAD need to take precaution when exercising, as the individual 
should be able to perform at an intensity permitting them to speak without 
breathlessness11 and exercise should be stopped when the rating of perceived exertion is 
17/20 or higher49. For individuals with COPD, exercise should be stopped when SpO2 
drops below 88%, or if there is a drop of 2% below the average SpO2.
50  
 Individuals with multiple chronic diseases are encouraged to exercise throughout 
the literature, but careful precautions must be taken to ensure it is done safely. When 
working with individuals with different chronic diseases, each disease has its own dosage 
for exercise prescription and markers, as well as overlapping markers for the clinician to 
consider when determining a safe and effective exercise program. 
Discussion  
The results of this review suggest that a systems-based exercise prescription 
process using overlapping physiological and subjective markers may be possible. As 
demonstrated from various existing exercise guidelines4,6-14, currently there is 
predominantly knowledge about exercise prescription taking into account for a single 
disease. The remaining question is how to prescribe exercise when an individual has 
more than one chronic disease? There are few specifics about how this can be 
accomplished using a systematic approach. Furthermore, guidelines often recommend 
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speaking to your healthcare provider about a safe exercise regimen for those with chronic 
diseases, yet lack of time, limited knowledge and education about exercise prescription 
are noted barriers to this tailoring approach.15-18 In order for individuals with chronic 
diseases to reap the benefits associated exercise and reduce risk of injury, safe ranges of 
physiological markers can be identified for clinician to guide their exercise prescription 
efforts.  
After looking at CAD, T2DM and COPD for the cardiovascular, endocrine and 
respiratory systems respectively there is evidence of overlapping markers that clinicians 
could use to determine safe exercise limits for individuals with chronic conditions. The 
most commonly overlapping markers across all three systems included SBP, DBP, RPE 
and HR. 
Each chronic disease has unique contraindications to exercise. As such, with this 
proposed system when the health care provider is first considering exercise for an 
individual all of the contraindications listed in the results9,13,19-21,41,44 must be cleared. If 
an individual has a chronic disease then contraindications unique to that disease must be 
cleared. This means that when an individual comes in with multiple chronic diseases, all 
contraindications to exercise must be cleared for all disease that are present. Given the 
complexity multiple chronic diseases can present, it is not surprising that one of the main 
reasons physicians often lack confidence with exercise prescription is due to limited 
knowledge.51 This stresses the importance of a system that can simplify the exercise 
prescription process while also emphasizing the importance of contraindication clearance. 
Furthermore disease specific markers can be monitored. For instance, COPD 
which represents the respiratory system, has a unique SpO2 marker that should be kept 
 
 
50 
above 90% in order to ensure body tissues adequately oxygenated,19,34,37,47 while 
individuals with CAD, representative of the cardiovascular system, must keep HR 10 
beats per minute below the threshold of angina symptoms.11,12 The HR staying below this 
threshold gives the health care professional confidence that there is very little risk that a 
cardiac event will occur. Lastly, individuals with T2DM representing the endocrinology 
system, must have their blood glucose levels between 100 and 300 mg/dLin order to 
prevent any serous symptoms while exercising.6,13,35 These examples clearly outline 
defined ranges of physiological markers that can be measured to determine 
appropriateness and safety of exercise. 
Furthermore, this review portrays an emerging pattern of overlapping 
physiological and subjective markers that could be used by clinicians to guide safe 
exercise. For the three system-based diseases investigated, there were overlapping 
markers between them. Blood pressure has been suggested for assessment and monitoring 
for T2DM, CAD and COPD. Findings from articles on all three diseases suggest keeping 
systolic blood pressure (SBP) between 160-260 mmHg and diastolic blood pressure 
(DBP) between 94-155 mmHg to ensure safety during exercise.21,29,31,47 For individuals 
with COPD and CAD, it is imperative to monitor HR, with safe limits ranging from 79.7-
142 bpm for those with COPD 34,37,47,48 and 10 bpm below angina threshold for those 
with CAD.11-12 Maximum VO2 is another physiological marker that was suggested in the 
literature as a guide for exercise intensity for people living with T2DM and CAD. For 
individuals with T2DM, studies recommended aerobic activity intensity should stay 
between 40 and 85% VO2max.
6,13,29,30,38,39,41,43-45 Four studies recommended a range of 
60-95% VO2max for individuals with CAD.
12,14,21,31 This demonstrates that overlapping 
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markers do exist across multiple chronic diseases, alluding to an innovative way for 
clinicians to prescribe and monitor safe exercise limits for individuals who have more 
than one disease.  
 One of the goals of this review was to determine whether key markers could be 
extrapolated for each of the cardiovascular, respiratory and endocrine systems. The three 
prevalent diseases presented in this review illustrate a potential way to begin extracting 
key physiological markers for respective body systems. For example, if an individual has 
either COPD or cystic fibrosis then the clinician would monitor the respiratory system 
and using table 10 below would know to monitor SpO2 and VO2 max. To further the 
previous example, if a clinician is prescribing exercise to a person with an endocrine 
disease and a cardiovascular disease then the clinician would know to monitor SBP and 
DBP as they overlap between systems. This review has shown initial evidence for key 
markers that should be monitored for exercise prescription and ongoing assessment of the 
effects of exercise. See Table 10 for the initial physiological markers that this paper 
suggests should be monitored.  
Table 10: Key physiological markers to be monitored for exercise prescription based on a 
body-systems approach. HR: heart rate; BP: blood pressure; VO2 max: Maximum volume 
of oxygen consumption. 
 Cardiovascular System Respiratory System Endocrine System 
Physiological 
Markers 
 HR11,12 
 BP9, 11,21 
 VO2 max12,14,21,31 
 SpO219, 34, 37, 47 
 BP34,47 
 RR34,37 
 Glucose 6, 13, 29, 30, 35, 44 
 BP13,29 
 VO2 
max6,13,29,30,38,39,41,43-45 
 
 This review demonstrates the complexity of developing a system that effectively 
ensures safety for those with multiple chronic diseases. It reveals the possibility of key 
physiological markers that could be screened in each of the 11 body systems. However, 
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the complexity of tailoring exercise programs by considering all key physiological 
markers form each system of the body in order to meet the needs of an individual with 
multiple disease is outside of the scope of this systematic review.  
This review has helped further demonstrate the complexity of exercise prescription 
considerations for individuals living with multiple chronic diseases.  
 The following algorithm (Figure 3) is proposed for clinicians to consider when 
working with individuals living with chronic disease(s). The application starts with an 
individual arriving in the clinical setting for an assessment. The clinician completes a 
subjective assessment and records a detailed medical history. If the individual has any 
single chronic disease, as determined by the history, the clinician would simply follow 
the current best-practice guidelines for exercise prescription with regards to that disease. 
If however, the individual is living with more than one chronic disease (such as T2DM 
and CAD) then the clinician will need to consider both disease-specific contraindications 
to exercise with the individual (such as severe autonomic neuropathy for T2DM and 
unstable angina for CAD). If the contraindications are cleared, the overlapping 
physiological and subjective markers for the two diseases then systematically guide a safe 
exercise prescription for that person. Furthermore, the same overlapping markers could 
then guide re-assessment during the following treatment sessions for exercise progression 
or individualized exercise prescription changes.  
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Cleared 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Exercise prescription guide for clinicians to use when working with individuals 
living with chronic disease(s).
Collect medical history 
from individual 
 
Individual has history of ONE OF 
CAD (cardiovascular), T2DM 
(endocrine) or COPD 
(respiratory system) 
Individual has history of 2 OR ALL OF CAD 
(cardiovascular), T2DM (endocrine) or COPD 
(respiratory)  
 
Follow the established 
single-pathology 
guideline 
Assess individual for all disease-specific 
contraindications to exercise 
 
Assess common physiological and 
subjective markers such as SBP, 
DBP, HR and RPE 
 
Prescribe AT and/or RT based on results of assessment 
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The results from this review show that for COPD, the clinician has to ensure that 
SpO2 levels stay above 90%,
19,34,37,47 and for CAD the individual’s HR must be kept 10 
beats per minute below one’s angina threshold.11,12 A limitation of this systematic review 
is that there are currently no physiological markers for T2DM that clinicians can monitor 
during exercise, since blood glucose can only be measured pre- or post exercise. This 
finding makes it difficult for clinicians to be confident that an individual with T2DM is 
not exercising in a danger zone. However, when working with people who have T2DM 
serious injury or death may be avoided as long as the clinician is aware of the signs and 
symptoms of hypoglycaemia and how to respond in case it presents. Ideally, having a 
physiological marker to monitor such as HR, RR, BP, or SpO2, could prove to be more 
informative and pragmatic with exercise considerations rather than solely relying on 
biological markers (e.g., glucose). 
Next, when the articles were reviewed for inclusion and exclusion from the 
systematic review, articles that had subjects with two chronic diseases, such as CAD and 
T2DM, were excluded from the study. Having these articles in the study would have 
confounded the generalization of the results. It would be difficult to ascertain if the 
results emerged due to CAD or T2DM. By the individual having two chronic diseases, 
the subjective, physiological and biological markers in these studies would be affected in 
unknown ways and the interpretation of results would be limited. It may be possible to 
compare the single article results with combined diseases to see if different conclusions 
would emerge.  
This review could have been strengthened if it focused on completing a review 
based on all currently available systematic reviews, to ensure greater comprehensiveness 
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covering a larger range of studies. Future researchers may want to develop a systematic 
review to analyze all current meta-analyses and systematic reviews to achieve a more 
comprehensive summary of the current knowledge of exercise prescription 
recommendations for individuals with multiple chronic conditions. 
This review presents the initial framework for a systems-based approach to 
exercise prescription for individuals with CAD, COPD and T2DM. The systems 
approach presented in this systematic review may be applied to many other chronic 
diseases in the future to create a more encompassing exercise prescription. The next step 
for this area of research is to examine other chronic diseases such as: hypertension, 
depression, arthritis and cancer for subjective, biological and physiological markers that 
will help inform exercise prescription for clinicians.  
Furthermore, future study focus can emerge from this initial attempt at a systems-
based exercise prescription is to analyze each body system in isolation and extrapolate 
safe ranges of key physiological markers unique to that system. For instance, HR is a 
marker associated with the cardiovascular system, which we have identified as one of the 
key factors to be monitored during exercise. Glucose is a biological marker associated 
with the endocrine system, which we know must remain in a specified range to prevent 
serious consequence such as hypoglycemia and in most severe cases, death. Thus, future 
researchers with sufficient resources may want to begin extrapolating markers per 
system, rather than disease, so that we can begin to tailor programs for the whole 
individual regardless of the disease(s) that is present. This might be achieved by 
screening all of the key markers from each body system before initiating an exercise 
program. This approach would truly step away from the dominant single disease-driven 
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guidelines and consider the full physiology of the person. The underlying hypothesis 
would be that if the key marker in each system is within the safe range, then regardless of 
the diseases present a safe and unique exercise program could be developed, 
implemented, and monitored.  
Lastly, the current model of “referring to your healthcare provider for a patient-
specific exercise program” is not ideal or necessarily safe for individuals living with 
multiple chronic diseases. This is an inadequate recommendation because it assumes that 
the healthcare provider has appropriate knowledge to create and implement a patient-
specific exercise program. Physicians often do not have exercise science training, yet are 
often encouraged to take the lead in exercise prescription.15-18 Chapter one findings 
suggest that PT’s may be best prepared to take on this role in primary care, but further 
research is required to consolidate or disprove these findings.  
Conclusion 
This systematic review acts as a stepping-stone for the emergence of standardized 
yet individualized exercise prescription, as it shows initial evidence for a multi-system 
approach to exercise prescription. Screening key physiological markers from various 
body systems in order to safely prescribe exercise to individuals with multiple chronic 
diseases may be possible and appropriate. Resistance and aerobic training exercise 
prescription can be safely tailored to individuals with CAD, COPD and T2DM. Disease-
specific contraindications and precautions to exercise need to be recognized and 
discussed within the clinical practice setting. Upon assessment and throughout treatment, 
safe ranges of key physiological and subjective markers need to be monitored for specific 
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exercises to be prescribed and implemented safely for individuals with or at risk of 
having chronic disease(s). 
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Chapter 4: The how of exercise prescription in primary care: 
A proposed approach 
 
Introduction 
 
 Primary care is the important first point of contact within the healthcare system, 
addressing health promotion, prevention, as well as diagnosis and treatment of illness and 
injury.1 This context provides an opportunity for appropriate providers to effectively 
implement exercise prescription and aid efforts in chronic disease prevention and 
management.  
 Limited time and knowledge have frequently emerged as barriers for physicians 
and nurses to effectively prescribe exercise within primary care.2-4 However, chapter 2 
demonstrated an opportunity to potentially address these barriers by delegating the role of 
exercise prescription to physiotherapists (PTs). Although knowledgeable on how to safely 
prescribe exercises for clients within their daily practice, opportunity for vulnerable 
groups (e.g., individuals with chronic diseases) to access PTs and reap the benefits of 
exercise prescription can be limited, since a small number of PTs work within publicly 
funded primary care settings.5 For example, it has been reported that from 267 hospitals 
in Ontario, as few as 197 had registered PTs and only 106 PTs were employed in the long 
term care (LTC) sector.6 Recognizing that one PT provides coverage in five LTC 
facilities, where each LTC services approximately 120 residents, a single PT is expected 
to provide appropriate, timely, and effective care to approximately 600 residents.6 In 
addition, one of the main primary care access points in Ontario includes the family health 
team (FHT) and until recently there were no PTs employed in FHTs. 7  
In order to begin improving access to necessary PT services, especially for the 
growing aging population, researchers have supported integration of PTs within primary 
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care teams.7 In support of this vision, as of 2013 interim funding was provided for 
primary care teams to apply for physiotherapist positions and target delivery of specific 
programs such as lung health, cardiovascular health, and healthy aging.8 More recently, in 
2014, 38.3 full time equivalent physiotherapist positions were made available in primary 
care organizations across Ontario. (8) These primary care organizations include: 1) 
family health teams (FHTs); 2) Community Health Centres (CHC); 3) Nurse Practitioner 
Led Clinics (NPLCs); and 4) Aboriginal Health Access Centres (AHAC). These timely 
changes present an opportunity for PTs to lead the exercise prescription movement by 
collaborating within well-established primary care teams. For instance, inclusion of PTs 
to prescribe exercise for chronic disease prevention and management efforts within multi-
disciplinary primary care teams promotes the inclusion of a health promotion and 
prevention piece that has historically been excluded from the current primary care system 
primarily designed to respond to acute health problems.9 This long-standing reactive 
approach cannot appropriately tackle chronic disease(s).  
A specific section of the Ministry of Health and Long Term Care (MHLTC) 
Framework includes improving the delivery system design (i.e., the way clinical practice 
is organized and delivered) to meet the needs for effective care delivery and chronic 
disease prevention. Re-designing clinical practice for clients affected by chronic disease 
requires that the most appropriate provider deliver expert care, while minimizing clients’ 
need to navigate the healthcare system alone. Given the complexity of chronic disease, 
effective care delivery for clients will require more than a single provider. Therefore, it is 
not surprising that interdisciplinary healthcare teams have shown improved care for 
individuals with chronic disease.9 Inclusion of well-prepared PTs within multi-
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disciplinary primary care teams to incorporate health promotion and prevention efforts 
through appropriate and tailored exercise prescription aligns well with MHLTC’s 
Framework to re-design the delivery system and begin addressing the complex needs of 
individuals with chronic disease.    
Although these are positive changes, with only 38.3 full-time equivalent 
positions, there is an expectation for a single PT to sometimes service anywhere between 
500 to 7000 patients within the primary care context.10 Thus, the traditional one-to-one 
PT service delivery is limited within such a setting and creative solutions to effectively 
address a population level health approach are necessary.10 That being said, special 
consideration is warranted for individuals with complex health needs, such as elderly 
with chronic diseases. In some instances, individuals will require direct and personal 
guidance to develop self-efficacy towards managing their health9 and the importance of 
tailored exercise prescriptions designed to meet their unique healthcare needs should not 
be ignored, or underestimated. Recently, 12 PTs from Ontario primary care teams were 
interviewed and they showed that PTs play unique roles in this setting as managers, 
evaluators, educators, collaborators, and advocates.11 Practice in this context often 
requires the PTs to push the boundaries to emphasize health promotion to meet the needs 
of clients within a changing healthcare landscape.11 Therefore, creative solutions are 
necessary in order to facilitate evidence-informed exercise prescription for those living 
with chronic diseases. 
 In this chapter, a guide on how exercise prescription might be effectively 
implemented within Ontario’s primary care context is presented, taking into account the 
complex needs of individuals with chronic diseases. Although some PTs report being 
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consulted about all physical activity needs of clients in primary care settings,11 even 
though they may not personally deliver exercise programs, an evidence-informed and 
systematic approach to guide exercise prescription for the management of multiple 
chronic diseases is limited.10  
Study1 and study 2, along with previous relevant literature informed the 
development of a two-phase conceptual model, which was designed to help guide 
decision-making and achieve a systematic, evidence-informed, and client-centered 
exercise prescription in primary care. First, the development process is described, 
followed by Phase 1, which introduces the exercise screening, including the interaction 
that ought to occur during the first point of contact between a provider (i.e., often a nurse, 
or a physician) and the client. Phase 2 then presents an exercise prescription process that 
incorporates key factors that ought to be considered for exercise prescription with 
individuals living with multiple chronic diseases. The chapter is concluded by a 
discussion of implementation considerations, including validation of the proposed 
exercise prescription approach, and potential barriers to implementation. 
The development of the proposed exercise prescription approach  
The proposed exercise prescription approach was developed by considering the 
limitations of the biomedical model and incorporating the important personal, social, and 
environmental factors. The biomedical model has an emphasis on disease—its etiology, 
pathology, and clinical manifestation,12  but it largely ignores the equally important 
personal and broader social determinants of health (e.g., socioeconomic status, 
environment, education, etc.).  These equally important factors will impact one’s action 
towards achieving health, which is defined by the World Health Organization (WHO) as 
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a “ complete state of physical, mental, and social well-being, and not merely the absence 
of disease”.13 The proposed exercise prescription approach was thus informed by the 5 
A’s model,14  findings from chapter 1 and chapter 2 of this thesis, established exercise 
guidelines,15  WHO’s definition of health,13  as well as previous literature on client-
centered care16 and health promotion.17  
 The first phase of the exercise prescription approach introduces the screening that 
ought to be completed by the first-point of contact clinician, which is often a nurse or a 
physician within the primary care context. Although, previous researchers have called 
upon physicians18-20 and nurses21,22 to incorporate exercise prescription into their daily 
practice, limited knowledge and time consistently emerge as barriers for these 
clinicains.2,4,22  On the other hand, study 1 and previous literature18,21  suggest that these 
providers are in a position to counsel, facilitate, or advocate for exercise. Therefore, 
primary care physicians and nurses are in a position to guide clients through Canada’s 
healthcare system towards appropriate care to reap the benefits of exercise. 
With this realization, the 5 A’s model, (comprised of the elements: ask, advise, 
assess, assist, and arrange) initially and effectively used by nurses and physicians in 
tobacco cessation efforts within primary care,14 was modified and adapted to help guide 
first-point of contact clinicians through the exercise screening process.  Sweeden23 
previously incorporated a version of the 5A’s model in their practice context to guide 
providers with exercise counseling, which further helped inform the development of the 
5A’s model in the exercise screening phase proposed in this chapter. Details of the 5 A’s 
model for the purpose of exercise screening are presented in the section entitled “Phase 1: 
the exercise prescription screening phase”.  
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 A key aspect discussed in greater detail within the second phase of the proposed 
exercise prescription approach, introduces a conceptual tool that accounts for important 
physiological factors that should be considered in order to ensure safety when developing 
an exercise prescription for those affected by chronic diseases. Inclusion of this aspect of 
the proposed exercise prescription approach was partially informed by study 2 of this 
thesis and previously established exercise guidelines.15 Specifically, focusing on the 
contraindications to exercise and key physiological markers that need to be monitored in 
order to inform an exercise prescription (i.e., exercise frequency, intensity, type, and 
time/duration). This physiological profile component of the exercise prescription tool has 
roots in the biomedical model,12 as key disease-specific factors are considered for this 
screen to ensure safety with exercise.  
However, the physiological profile is only one aspect of the proposed exercise 
prescription tool. Another key component incorporates a personal profile, comprised of 
elements such as individuals’ activity preferences, economic means to participate in 
exercise, transportation mode, environmental considerations, and other personal factors, 
which are proposed as important for consideration when developing the initial exercise 
prescription. The decision to include personal factors in the initial exercise prescription 
was informed in-part by considerations of the International Classification of Functioning, 
Health and Disability model and the Institutes of Medicine’s enabling-disabling process 
model,12  which recognize that a person’s participation in activities may be influenced by 
the person, as well as their physical and social environment.  
Finally, another fundamental component of the exercise prescription approach 
includes clinical reasoning and collaboration with the client. This clinician-client 
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interaction helps modify the tool’s initial exercise prescription in order to develop a truly 
tailored program that is relevant and meaningful to the person’s life context. This is a 
fundamental component, as it ensures that the client is central during the exercise 
prescription development process. Therefore, the final tailored exercise prescription is an 
outcome from the agreement reached between the clinician and the client, informed by 
the client’s physiological and personal factors, clinical reasoning, and client’s 
feedback/collaboration. In other words, the content of the final exercise prescription 
(paper or digital copy) is created with the client, not something that is simply given to the 
client. 
The decision to provide a copy (e.g., paper or digital) of the exercise prescription 
was informed by previous evidence, which showed that providing an exercise 
prescription or a specific printout led to better compliance24 and a 15-50% increase in 
physical activity.25 Thus, in addition to the physiological profile and disease-specific 
safety considerations that largely stem from the biomedical model, broader concepts of 
health (i.e.,WHO’s definition,13 IFC and The Institutes of Medicine’s enabling-disabling 
process model12), health promotion (i.e., enabling individuals to take control over their 
own health17) and client-centered care literature16,26 (i.e., the client is a well-informed and 
active participant in decisions regarding their health) all provided key building blocks 
that helped inform the foundation of the proposed exercise prescription approach.   
Being aware of the background that informed the development of the proposed 
approach enables the reader to recognize how each phase of the proposed model was 
conceptualized. The following sections provide details of each phase that comprise the 
overarching conceptual exercise prescription approach proposed in this chapter.   
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Phase 1: The exercise prescription screening phase 
 In primary care an individual’s first point of contact will often be with a physician 
(MD) or a nurse (RN). With respect to exercise prescription, previous research2,22,27,28  
and chapter 2 from this thesis indicate that neither of these professionals is formally 
prepared to prescribe an appropriate exercise program. However, RNs, MDs, and PTs 
were all identified as being well prepared to counsel clients regarding the benefit of 
exercise.18,22,29 Thus, all of these clinicians can participate as exercise facilitators, or 
advocates to help with chronic disease management efforts. 
An established 5 A’s model for smoking cessation has been used in public health 
and primary care.14,30 The 5 A’s model is comprised of five key elements, including: Ask, 
Advise, Assess, Assist, and Arrange. Given the simplicity, familiarity, and its 
effectiveness,14 the 5 A’s are applied for the purpose of illustrating how the first point of 
contact clinician (e.g., often an MD or RN) in primary care may advocate or facilitate 
exercise participation. The two columns in Box 1 compare how the 5 A’s model can be 
translated from the tobacco cessation mandate30 to the clinicians’ role in the exercise 
prescription screening phase. 
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Box 1: Application of 5A’s from tobacco cessation to exercise prescription  
Tobacco cessation: Exercise prescription screening phase: 
 
ASK all clients about tobacco use at 
every contact with all clients.  
Example: “Have you used tobacco in the 
last 6 months”? Document tobacco use 
status.   
 
ASK all clients about exercise habits at every 
contact.  
Example: “How often do you exercise?” 
ADVISE all tobacco users to consider 
quitting.  
Example: Urge every tobacco user to 
quit in a way that is personally relevant.  
ADVISE all clients to participate in exercise. 
Example: Discuss benefits of exercise and 
encourage every client to participate in 
exercise that is personally relevant.  
ASSESS tobacco users’ readiness to quit 
Example: ask every tobacco user if they 
are ready to make a quit attempt at this 
time. Assess how important it is for them, 
and how confident and ready they are to 
make a change.  
ASSESS client’s readiness to start exercising  
Example: Ask every client if they are ready to 
start an exercise program. 
ASSIST according to client 
readiness/stages of change  
Example: help the patient make a plan to 
quit smoking.  
ASSIST according to client’s readiness/ 
stages of change.  
Example: assist the patient to make a plan to 
meet with PT to begin an appropriate 
exercise program.  
ARRANGE for referral and follow-up  
Example: Smokers’ Helpline, contact 
your local public health unit.  
ARRANGE for referral and follow-up.  
Example: Refer client to PT for an exercise 
prescription: follow-up during check-up 
appointments how the exercise program is 
going for them.  
 
An elaboration of each section of the 5A’s model is provided to further illustrate 
the screening phase and how this model might be operationalized within the primary care 
context.  
Ask. The Ask component is operationalized during the first visit with a client. It 
determines the individual’s exercise tendencies, in order to ascertain if the client requires 
additional support to commence an exercise program. There are several questions that 
may assist the clinician in determining if a client is participating in regular exercise, such 
as:  
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- Do you engage in regular exercise?  
- How often do you exercise? (e.g., frequency: daily, twice per week, etc.)  
- How long do you exercise? (e.g., duration: minutes per session) 
- How intense is your exercise? (e.g., rate of perceived exertion)  
- What do you do for exercise? (i.e., type: walking, swimming, weight-lifting, etc.)  
These five questions are meant to determine if the client has a consistent exercise 
program and/or if they are in need of further assistance to commence exercising. If a 
client reports that they do not exercise, the clinician can proceed to the Advise stage of 
the 5 A’s model and share information about the benefits of exercise with the client.  
On the other hand, if a client reports already participating in exercise the first-
point of contact clinician may ask follow-up questions to determine if additional supports 
are needed. For example, if the client shares that they have been exercising, the first-point 
of contact clinician may still decide to refer this client to a PT for instance to modify, or 
progress the client’s exercise program in order to achieve additional health benefits 
and/or minimize risk of injury.   
Advise. The key aspect of the Advise component is that the client is informed 
about exercise and how an exercise program leads to benefits that are important or 
relevant to the client. For example, if a person with diabetes and arterial insufficiency 
shares that they love gardening, but are no longer able to enjoy it due to increased 
discomfort with activity, the first-point of contact provider can discuss with this client 
that they might be able to enjoy gardening with an appropriately designed exercise 
interventions that targets key components that are currently limiting their gardening 
participation (e.g., back pain, lower extremity weakness, etc.). The key purpose of this 
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stage is to inform the individual with chronic disease(s) how an appropriate exercise 
program could be beneficial and that there are appropriate supports to facilitate their 
involvement.  
Assess. The Assess stage is where the clinician becomes informed about client’s 
readiness to begin an exercise program. The Transtheoretical Model (TTM)31-33 and the 
stages of change are used to illustrate how the clinician can ascertain client’s readiness to 
commence an exercise program.   
1) Pre-contemplation is the stage where a client is not ready to start exercising. 
2) Contemplation is when a client is thinking about starting an exercise program.  
3) Preparation occurs when a client is ready to commence an exercise program.  
4) Action occurs when the client has started an exercise program.  
5) Maintenance stage is when a client is exercising for six months to five years.  
6) Termination occurs when a client has no risk of relapse and exercise becomes a 
lifestyle they no longer need to think about, such as putting on shoes when leaving 
your house.   
In reality, the termination stage is unlikely to be reached, but maintenance may be 
a more realistic goal, where regular exercise becomes a component of a person’s daily 
lifestyle, with occasional interruptions being a normal way of life (e.g., appointments 
getting in the way of exercise, injury or acute-illness, etc.,). The client should at least be 
in the preparation stage, or express that they are ready to commence an exercise program, 
in order to proceed to the Assist stage of the 5 A’s model. Otherwise, the clinician may 
need to spend some time moving from Ask, Advise, and Assess components of the 5 A’s 
model, until the client reaches TTM’s preparation stage. Even after an exercise program 
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has been arranged, during follow-up, the clinician may repeatedly need to Ask, Advise, 
Assist, and make new arrangements with the client. Therefore, just as the stages of 
change occur as a spiral, with relapse being a realistic occurrence during the change 
process, the 5A’s are also fluid and more cyclical rather than linear in nature. 
Assist. Once the client is prepared to commence an exercise program the clinician 
ought to determine their risk level. For instance, a client who has a well-managed chronic 
disease, without any complications or comorbidities, may benefit from attending a 
general community-based exercise program at a community center, or a fitness facility. 
However, for clients who have multiple diseases, arranging an appointment with a 
physiotherapist to develop a tailored exercise prescription may be more appropriate. 
Therefore, in this stage the client’s risk profile is determined so that they may be 
appropriately assisted with navigating the healthcare system to reach the next stage where 
a specific action can be arranged.9   
Arrange. Once it is determined that a client is prepared to commence an exercise 
program and that they require a tailored exercise prescription to meet their unique and 
often complex healthcare needs, an appointment with a PT ought to be arranged. There 
are several options that the client may have to access physiotherapy for the purpose of 
chronic disease management. For example, if a PT is available within the primary care 
setting, such as the FHT, where an RN or MD initially saw them, an appointment with 
the in-house PT can easily be arranged. However, given that there are fewer than 40 full-
time equivalent PT positions that recently opened in Ontario’s primary care system, 
chances are a primary care team may not have a PT member. In such an instance, the 
client may be connected with a Community Care Access Center (CCAC) to arrange a 
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home-care physiotherapy session, or attend a local private clinic to see a PT. It should be 
noted that if the client is over 65 years old they are automatically eligible for the episode 
of care program,34 which means that a PT in a clinic will receive $312/episode of care 
(current figures), which is publically funded within private PT clinics (see the Ministry of 
Health and Long Term Care35 for a list of participating clinics). Episode of care refers to 
a discrete group of conditions when specific, time-limited, goal oriented physiotherapy 
services are appropriate. The episode of care program has no pre-set limits to the number 
of visits. Instead, the PT and the client identify specific goals for treatment, which then 
guide the total number of visits. Once these goals are achieved, or no further gains are 
likely to be achieved with continuing PT service and/or if equivalent gains can be 
achieved through self-care, or community programs (e.g., falls prevention, exercise 
classes) the client is discharged. 
Despite these various options, primary care teams provide a unique opportunity 
for clients requiring complex care needs to access publicly-funded healthcare services, 
delivered by diverse providers within a single location. This practice context enables easy 
knowledge sharing between clinicians within a multi-disciplinary team and improves the 
likelihood of achieving better quality, client-centered care.9 Given the complexity of 
chronic disease management, a team-based collaboration fits well with the previously 
discussed Ministry of Health and Long-Term Care Framework for chronic disease 
prevention and management.9 
Follow-up Appointment. Once an appointment is made with a PT provider, 
regular follow-ups need to be scheduled to facilitate client compliance.9 These follow-ups 
may be achieved through telephone conversations, e-mails, text-messages, or in-person. 
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The mode of follow-up is not as important as is consistency, since it has been previously 
shown that regularly scheduled follow-up telephone calls improved clients’ health more 
than irregular in-person follow-ups.9 If the client indicates that they have not commenced 
an exercise program during the follow-up visit, the clinician may proceed by following 
the 5A’s model again until the client receives an appropriate exercise prescription. Figure 
4 illustrates the application of the 5A’s model during the exercise prescription screening 
phase.  
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Legend: CCAC: Community Care Access Center; FHT: family health team; 
CHC: Chronic Health Center; NPLC: nurse practitioner led clinic; 
AHAC: Aboriginal Health Advocacy Center. 
 
Figure 4: Example of the exercise prescription screening phase.  
 
 
 
 
Phase 2: The exercise prescription tool and process  
ASK 
Do you 
exercise?  
yes 
ADVISE 
ASSESS 
 
 
ASSIST  
 
ARRANGE 
no 
1) Pre-contemplation  
2) Contemplation  
 
3) Preparation  
4) Action  
5) Maintenance  
6) Termination  
Follow-up questions:  
1) how often do you exercise; 2) what type of 
exercise do you do; 3) how long are your exercise 
sessions; 4) how intense is your exercise?  
Primary 
Care 
FHT 
CHC 
NPLC 
AHAC 
 
 
 
Determine client’s 
risk profile. If risk is 
high (e.g., >1 
chronic 
diseases/multiple 
comorbidities), 
proceed to arrange. 
FOLLOW-UP 
Mode 
- in person  
- telephone  
- e-mail  
 
Frequency  
- Weekly  
- Monthly  
- Yearly  
 
Community 
-CCAC 
 
 
Clinic 
-EOC 
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 While the first phase of this chapter proposes a screening approach that may be 
completed by any initial contact clinicians in primary care, in order to facilitate and/or 
advocate for exercise, phase 2 introduces a conceptual exercise prescription tool and 
process. This tool and process is meant to factor in the complexity of chronic diseases 
and begin addressing how an exercise prescription might be tailored to meet the unique 
needs of individuals often living with more than a single chronic disease. An exercise 
prescription should include specifics about the type of exercise, frequency, intensity, and 
duration.36,37 These specific elements should be included when an exercise prescription is 
given to the client and it ought to be informed by the individual’s unique characteristics. 
The proposed tool attempts to identify and capture these characteristics in order to show 
how an exercise prescription can be tailored to meet the individual needs of a person 
living with chronic disease(s). However, prior to the provision of the final exercise 
prescription, clinical reasoning and client collaboration is crucial in order to modify the 
program to suit the unique needs of the client. Thus, PTs’ clinical reasoning and the client 
are central in the process as they ultimately co-create the final exercise prescription.  
For the purpose of the proposed tool, the factors that can influence exercise 
prescription are categorized into the physiological profile and the personal profile. The 
physiological profile refers to chronic diseases the client may have, while the personal 
profile includes consideration of individual characteristics that can influence exercise 
participation, such as personal preferences. Furthermore, social determinants of health 
such as income, employment, and the built environment also fit within the personal 
profile, since they may influence one’s ability to be active.38 Consideration should be 
 
 
78 
given to all of these elements for an exercise prescription to be relevant, realistic, and 
meaningful for an individual and their personal lifestyle context.  
Boudreau and colleagues39 recently found that a computer-tailored, print-based 
exercise intervention provided to French-Canadians with type 2 diabetes led to greater 
compliance to exercise than generic activity recommendations. Building on these 
findings, the proposed exercise prescription tool introduces examples of algorithms that 
could be computerized in the future to expedite the application of a tailored exercise 
prescription. Figure 5 shows the exercise prescription process, including components of 
the electronic tool, clinical reasoning, and client collaboration, all contributing to a 
tailored exercise prescription as the final outcome.  
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TOOL      PROCESS 
 
 
 
 
 
 
                  OUTCOME  
Legend: PT: physiotherapist; RT: Resistance Training; AT: Aerobic Training; *Personal 
preference to exercise within a group or as an individual. 
 
Figure 5: Exercise Prescription Process.  
 
 
 
 
 
 
 
 
 
 
Exercise Prescription 
given to client 
(print/digital copy) 
Physiological 
Profile  
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Profile   
RT 
AT 
AT+RT 
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Prescription   
Tool produces an 
initial exercise 
prescription 
(type, intensity, 
frequency, 
duration) 
Modify Prescription  
(based on client feedback 
AND clinical reasoning)  
Group* 
Agreement 
Reached between 
PT and Client  
Individual* 
PT + Client 
Discuss 
Prescription   
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What is meant by the physiological profile? The physiological profile refers to 
the client’s chronic diseases, which will inform the specific contraindications to exercise. 
Given that there are currently established exercise guidelines for over 49 chronic 
conditions15 future efforts might enable extrapolation of key physiological factors from 
various systems of the body (cardiovascular, neurological, endocrine, etc.,) to inform 
individualized exercise prescriptions. Extracting key physiological factors from over 49 
chronic diseases is outside of the scope of this thesis, but a small-scale example is 
provided to demonstrate how key factors from established exercise guidelines15 might be 
incorporated into a computer-based tool to guide a tailored exercise prescription. The 
proposed tool’s software would expedite the analysis of various contraindications using 
appropriate algorithms to determine a risk assessment unique to the client’s physiological 
profile. The tool would initially indicate whether it is safe for a person to commence an 
exercise program. The necessary data to inform the client’s physiological profile could be 
obtained from the electronic medical record (EMR), or a combination of questionnaires 
and diagnostic test results. Appendix I provides an example of the type of data that might 
be considered by the tool and an example of the algorithm that would help guide the 
decision process leading to an exercise prescription or an alternative recommendation. 
 To help illustrate, a case example is presented, informed by the leading chronic 
diseases reviewed in chapter 3 of this thesis. If a person with type 2 diabetes mellitus 
(T2DM), coronary artery disease (CAD), and chronic obstructive pulmonary disease 
(COPD) was prepared to initiate an exercise program, the physiological profile would 
need to account for the contraindications to exercise first, before a tailored prescription is 
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developed. Table 11 includes the list of contraindications for each of the three leading 
chronic diseases presented in chapter 3.  
Table 11: Chronic diseases and their respective contraindications  
Chronic Disease Contraindications  
Type 2 Diabetes Mellitus  Autonomic neuropathy  
Severe peripheral neuropathy  
Pre- or proliferative retinopathy  
Coronary Artery Disease  Unstable angina  
Uncontrolled arrhythmia  
Stenotic/uncompensated valves 
Hypertrophic obstructive cardiomyopathy 
Chronic Obstructive Pulmonary Disease Severe hypertension  
Hypoxemia with oxygen below 85% 
Uncontrolled angina 
Congestive heart failure  
 
The initial question is whether commencement of an exercise program is safe. 
Then, informed by current evidence the tool should determine specific exercise (type, 
duration, intensity, frequency) that is appropriate for the client. The algorithm below 
illustrates how the tool could sort through this process. In the first instance, one will see 
that if a contraindication is not cleared that exercise is not a safe outcome and thus an 
exercise prescription is not provided.  However, as a clinician there are alternative 
outcome options that may still provide beneficial information for the client, such as 
education (e.g., falls prevention, breathing strategies, safety considerations for activities 
of daily living, or any other details relevant for the client’s unique healthcare needs).  On 
the other hand, if all contraindications are cleared and exercise is determined to be a safe 
option for the client, the tool would retrieve the evidence from established exercise 
guideline and provide appropriate, initial exercise prescription options for the client.  
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Disease   Contraindication (Yes/No)  Exercise Safe (Yes/No)  
 
T2DM    1) YES     NO--Resolution Needed 
   2) NO     YES 
   3) NO      YES  
CAD   1) NO     YES 
   2) NO     YES  
   3) NO     YES 
   4) NO     YES 
 
 
Next Steps   
Resolution  
Options 
Contraindication 
Cleared (Yes/No) 
 
Outcome  
- pharmacological  
- surgical  
- MD consult 
- counseling 
- alternative medicine 
           NO  
 
 
 
 
            
 
           YES 
Exercise  NO  
 
Advice  YES  
e.g., Education that is 
clinically relevant for 
client. 
 
Exercise  YES 
Type: RT 
Frequency: 2-3x/week 
Intensity:  50-80% 1RM 
Duration: 1-4 Sets 
 
Type: AT  
Frequency: 5-7x/week 
Intensity: 2-6 RPE 
Duration: 30-60 minutes 
 
Legend: T2DM: type 2 diabetes mellitus; CAD: coronary artery disease; COPD: chronic 
obstructive pulmonary disease; 1RM: 1 repetition maximum (the maximum amount of 
resistance that can be lifted once); RPE: rate of perceived exertion (e.g., scale: 0-10 
where the a higher number denotes greater activity difficulty as perceived by the 
individual completing the exercise)    
 
Figure 6: Example of a physiological profile algorithm.  
 
 
Next Steps 
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 What is meant by the personal profile? The personal profile would be included 
in the tool to incorporate individual factors that may influence a client’s preference for 
certain activities, and/or indicate resources to facilitate exercise participation. The tool 
would include client data such as demographics, geographic location, and client’s 
exercise preference, when possible, obtained before the initial assessment. For example, a 
questionnaire (Appendix J) could be e-mailed or completed over the telephone with the 
client prior to the first in-person meeting, which could maximize the time the clinician 
spends interacting with the client during their first visit to begin developing a tailored 
exercise program that is meaningful to the person. Otherwise, the data could be retrieved 
and entered into the tool during the first visit. Figure 7 presents an example of a personal 
profile algorithm, informed by questionnaire in Appendix J, for the purpose of 
developing a tailored exercise prescription. Additional information can also be added, 
such as income or the amount of financial investment one can afford towards an exercise 
intervention. These broader questions are aimed at assessing some of the key social 
determinants of health, such as income, employment, and the built environment, to help 
assess the potential access to appropriate services for the client. These factors were taken 
into account since considering a person’s living context can improve likelihood of 
success with an intervention.9  
 
 
 
 
 
INPUT PROFILE   OUTPUT 
Exercise recommendation based 
on the personal profile 
1) Location(s): list of local 
Facilities (e.g., private 
clinics or gyms with 1:1 
personal training)  
2) Senior (>65): eligible for 
Episode of care  
3) Distance: Treatment 
facilities located 20-50 km 
from client’s postal code 
4) AT+RT (discuss options)  
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Legend: AT: aerobic training; RT: resistance training; AT+RT: combined 
aerobic and resistance training. 
 
Figure 7: Example of a personal profile algorithm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
As shown in Figure 5, both the physiological profile and the personal profile are 
combined in order to inform the initial exercise prescription. The clinician can then spend 
time discussing the initial exercise prescription with the client and modify it based on 
Age 
Postal code  
Transportation 
Type of Exercise  Mode 
Distance  
AT 
RT 
AT+RT 
Group  
Individual 
Client’s Location 
 
>65 years old  
AT+RT 
Individual:  
- 1:1care 
- exercise at a facility  
Car 
20-50 km   
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clinical reasoning and client feedback, prior to completing a mutually agreed-upon 
exercise program that is tailored and appropriate for the client.  
Implementation Considerations 
Previous sections of this chapter introduced the theoretical algorithms that could 
guide the how of exercise prescription within primary care, for the purpose of chronic 
disease management. However, there are implications that need to be considered before a 
practical exercise prescription tool can be prepared for implementation. This section will 
further elaborate on the following implementation considerations: 1) validation of the 
proposed exercise prescription approach, and 2) potential implementation barriers.  
Validation of the proposed exercise prescription approach. At this point the 
exercise prescription approach is conceptual in nature and before extensive resources are 
allocated into further development, validation of the proposed approach is necessary. An 
appropriate technique that could be employed to begin validating the proposed approach 
is the Delphi technique, primarily developed by the Rand Corporation in the 1950s and 
Dalkey and Helmer (1963).40  Previous researchers41  suggest that the Delphi technique 
can be used for the following:  
“1) To determine or develop a range of possible program alternatives; 2) To explore or 
expose underlying assumptions or information leading to different judgments; 3) To seek 
out information which may generate a consensus on the part of the respondent group; 4) 
To correlate informed judgments on a topic spanning a wide range of disciplines and; 5) 
To educate the respondent group as to the diverse and interrelated aspects of the topic” 
(p11).  
 In other words, this technique can be used for consensus building to determine 
whether the proposed exercise prescription approach is appropriate for the primary care 
context. Hsu and colleagues40 provided an in-depth review on how the Delphi process is 
employed to reach consensus. The reader is directed to this review for extensive details, 
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but a general summary of the process is provided to help illustrate how the validation of 
the proposed approach can be commenced.  
The Delphi process begins with round one, where an open-ended questionnaire is 
distributed to solicit specific information from relevant participants or a panel of experts. 
In this instance, it would consist of primary care team members, including MDs, RNs, 
and PTs, since the proposed exercise prescription approach would directly impact this 
group of professionals. Upon attaining approval for a Delphi study by an appropriate 
ethics board, convenience sampling would be completed to connect with primary care 
teams that employ MDs, RNs, and PTs. There are currently 150 primary care teams in 
Ontario, and to improve likelihood of the consensus being representative, there should be 
a primary care team from diverse regions across Ontario, including both rural and 
municipal teams.  After participating teams are secured, the participants would be sent all 
necessary details and background of the proposed exercise prescription approach along 
with the first round of questionnaires. The participants would be provided with 
approximately 2 weeks to review the background information and complete the first 
round of questionnaires. Although the traditional Delphi technique uses open-ended 
questionnaires to assist the development of the second round of questions that are more 
specific based on participant feedback, a modified Delphi process can be used instead 
where a structured survey is employed based on an extensive literature review of basic 
information concerning the issue. The modified Delphi process may be appropriate for 
the purpose of reaching consensus regarding the proposed exercise prescription approach, 
as long as the participants are provided with the background information and the details 
of the conceptual model described in this thesis.  
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 Once the initial data from the first round of questions is obtained, the panel of 
experts would receive a second survey to review the summary of their initial responses 
and rank the items to determine priorities.  For example, participants may rate that having 
a tool screen through key contraindications to inform their prescription process is more 
important, than including the screening phase or the 5 A’s model. This is the phase where 
agreements and disagreements amongst participants are identified, thereby initiating the 
formation of consensus. Following along is the third round where each of the participants 
is provided with the questionnaire that now includes the items along with ratings, and the 
participants are asked to revise their judgments, or to elaborate reasons for remaining 
outside of the consensus achieved in round two. The outcome of round three is to fine-
tune the consensus from the second round. Finally, round four of the Delphi process aims 
to provide participants one last opportunity to modify their judgments before the final 
consensus is reached.  
 The Delphi technique would be a valuable first step in the validation of the 
proposed exercise prescription approach. The primary consensus that would need to be 
reached regarding the exercise prescription approach includes addressing several key 
questions. For example:  
1) In your expert opinion, would an evidence-informed and systematic approach be 
useful to facilitate exercise prescription for individuals living with more than one 
chronic disease(s)?  
2) In your expert opinion, would you use the 5 A’s model (described in your 
background information package) to facilitate exercise advocacy?  
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3) Based on the physiological and personal profile algorithms that you have 
reviewed, do you think that a tool designed to systematically analyze such data to 
inform your exercise prescription would be useful?  
4) Would you use the proposed exercise prescription tool if it were developed?  
5) What, if any, barriers do you think would exist with using the proposed exercise 
prescription approach?  
6) In your expert opinion, should the proposed exercise prescription approach for the 
purpose of chronic disease management be implemented in primary care?  
7) Please share further thoughts that were not addressed directly in the 
questionnaire?  
As shown by the sample of potential questions, a consensus would need to be 
reached regarding three major themes: 1) usefulness of the proposed exercise prescription 
approach in primary care; 2) barriers to implementation; and finally, 3) if further steps 
ought to be taken to further develop the proposed approach. One of the main reasons for 
starting the validation process with the Delphi technique is due to the relevance of the 
proposed exercise prescription approach and tool where the Delphi method attempts to 
address what could/should be done. 40  
If consensus is reached (i.e., 90-100% agreement per item/question amongst 
participants) that the proposed exercise prescription approach is worth developing further, 
the next step would include organizing a team of experts to develop an implementation 
protocol for the proposed exercise screening (5A’s) and a preliminary software-based 
exercise prescription tool that takes into account the physiological and personal profiles 
described earlier. Once the tool based on initial algorithms proposed in this study is 
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finalized, it could be pilot tested within primary care teams across Ontario and later on 
across Canada. The purpose of the pilot test would be to further validate the exercise 
prescription approach by conducting a process evaluation to determine if and how it 
could be implemented in the primary care context, while an outcome evaluation would 
follow the process evaluation to help inform the effectiveness of the implemented 
exercise prescription approach. 
Potential implementation barriers. There are several potential barriers that 
could limit the implementation of the proposed exercise prescription approach, which are 
subdivided and elaborated further within the following categories: 1) Financial; 2) 
Access; 3) Time, and; 4) Acceptance of PTs’ role in chronic disease management.  
Financial. Developing an effective electronic tool to facilitate efficient exercise 
prescription for individuals with multiple chronic disease(s) can be an expensive 
endeavor. For instance, Canada Health Infoway invested over $1.2 billion by 2004 
towards optimizing the use of electronic health/medical records (EMR).42 Despite this 
large investment, data from 2006 Commonwealth Fund International Health Policy 
Survey of Primary Care physicians showed that only 23% of primary care physicians use 
EMRs in Canada, compared with 89% in the United Kingdom.43 Concerns such as cost, 
privacy, security, and design likely contributed, at least in part, to the low adoption rate of 
EMRs in Canada’s primary care system.44  That being said, a more recent Ontario survey 
in 201045 showed that there is an increase in the use of EMRs, which suggests that 
technological tools are becoming more accepted within the primary care context. 
Increased adoption of health-based technology systems can lead to improved 
management of individuals with chronic disease, by improving their ability to document, 
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as well as follow-up adverse outcomes, and improve implementation of practice 
guidelines.43,46 Thus, the cost of developing an effective, technologically-based tool to 
assist primary care providers with tailoring exercise prescription for individuals with 
multiple chronic diseases presents a potential barrier for implementation. Future financial 
and needs assessments ought to be completed to determine if the proposed approach is a 
cost-effective and viable solution for the primary care context. In addition to the cost 
associated with developing a comprehensive exercise prescription approach, 
consideration ought to be given to Canada’s healthcare system and its funding structure, 
which directly impacts the potential access to necessary care and is further discussed 
next, as another potential barrier to implementation. 
Access. Historically, Canada’s publicly funded (Medicare) healthcare system was 
founded on the philosophy that access to healthcare should be based on need and not 
one’s ability to pay.47 Canada’s Health Act guided the legislation where all medically 
necessary services are covered by the publicly funded sector. This philosophy of practice 
enables clinicians or healthcare professionals to deliver care in the best interests of clients 
without financial compensation influencing their decisions. 
At this time, PT services are funded through both public and private sources, with 
increased privatization presenting a potential barrier to effective implementation of the 
proposed exercise prescription approach.7 As mentioned earlier, recent inclusion of 
Ontario PTs in primary care provides an opportunity to improve access for clients to 
receive necessary care in one location. However, a primarily population-based approach 
to care delivery is needed, since fewer than 40 full-time equivalent positions were made 
available for PTs in primary care. 10 This approach might be effective for some clients, 
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but individuals with more complex healthcare needs will often require one-on-one care to 
ensure that safe interventions are implemented.  
Although PTs may be best-prepared to lead exercise prescription for the purpose 
of chronic disease management, inadequate publicly accessible options could limit the 
provision of care to those who need it the most. It has been previously reported that two 
main reasons that primary care physicians do not refer clients to PTs include increased 
privatization making PT care too expensive and a long waiting list for publicly funded PT 
programs.5 Individuals with chronic musculoskeletal conditions, cardiopulmonary 
conditions and general debility, such as elderly with chronic disease, were at least three 
times more likely to receive PT services at publicly funded than privately funded practice 
settings.5 This means that the current structure of PT service delivery in the community 
limits access to necessary care. Home-care programs, such as those offered through 
Community Care Access Centers or the Community Health Centers, have enabled access 
for some clients who could potentially benefit from a tailored exercise program, but there 
is little to no direct interaction and collaboration with multi-disciplinary clinicians in 
these settings.5 Such an environment may not be optimal for the implementation of the 
proposed exercise prescription approach. Thus, inappropriate or limited access to 
necessary care poses another potential barrier.  
With the new addition of PTs into family health teams, the accessibility gap may 
slowly begin to decrease. However, recognizing the complexity and related need for one-
on-one care delivery suggests that a greater number of primary care PTs will eventually 
be required to effectively implement appropriate, tailored, and comprehensive exercise 
prescriptions. 
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Time. Although the proposed exercise prescription approach is meant to be 
comprehensive and expedite efficiency of exercise prescription through utilization of an 
electronic tool, time can present a barrier to implementation. Time has often been 
highlighted as a common barrier to incorporating exercise prescription in primary care.48  
With the proposed exercise prescription approach, MD’s and RN’s involvement takes on 
the role of exercise advisors or facilitators. Therefore, time demands, albeit brief and less 
demanding than the development of a full exercise prescription, could still present a 
barrier that could limit acceptance and implementation of the proposed approach by all of 
the primary care providers. On the other hand, the electronic tool aims to expedite 
exercise prescription for the PTs, but a potentially significant learning curve is likely to 
be expected, which places a demand on PTs willingness to commit their time to learn 
how to use the new exercise prescription tool. 
Acceptance of PTs role in chronic disease management. Acceptance by the 
public as well as the healthcare community of PTs role in chronic disease management 
may present a barrier to implementing the proposed exercise prescription approach. 
Previous research suggests that even when family health team members like MDs and 
RNs perceive PT as being important, there is often a lack of understanding on the part of 
referring MDs and RNs as to what PTs can accomplish.7 Thus, it may not be as surprising 
that physicians have been found to underuse rehabilitation services that currently exist, 
particularly in the care of elderly and those with chronic diseases.5 In addition to primary 
care providers’ acceptance of PTs for chronic disease management, the public may have 
limited understanding and acceptance of PTs scope of practice, with limited knowledge 
of their relevance for chronic disease prevention and management.23,49 Therefore, primary 
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care providers’ and the public’s limited understanding of PTs role in chronic disease 
management present potential barriers to implementing the proposed exercise 
prescription approach.  
Conclusion 
 The proposed exercise prescription approach may benefit the Canadian 
population. Recognizing the well-acknowledged benefits of exercise50-54 (improvement in 
function, decrease in pain, and reduction of morbidity as well as mortality) and that over 
half of the population 65 years of age and older have more than one chronic disease,55 
presents a strong case that despite the barriers, efforts towards establishing effective and 
efficient exercise prescription within primary care is a worthwhile endeavor.  
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Chapter 5: Final Discussion 
Introduction  
 Chronic diseases are a growing global epidemic, attributing to the death of over 
36 million people per year worldwide.1 Closer to home, 67% of Canadians who die every 
year succumb to either cancer, diabetes, cardiovascular, or chronic respiratory diseases.1 
Canadians of all ages are affected by chronic disease and although seniors are living 
longer they are often burdened by multiple chronic conditions.1,2 This growing epidemic 
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has contributed to a significant personal and economic burden. For example, 2008 figures 
showed that the total burden of illness and disease in Canada was $192.8 billion, with 
direct costs reaching $175.6 billion and indirect costs were at 17.9 billion.3,4 The 
contributing cost of only three chronic conditions (cardiovascular, diabetes, and 
respiratory disease) cost the Canadian healthcare system approximately $18 billion in 
2008.4   
 There are numerous factors that contribute to the growing chronic disease burden. 
Some of these are modifiable risk factors such as tobacco use, excessive alcohol 
consumption, unhealthy diet, and physical inactivity,3,5 while broader considerations 
include, social and economic factors, such as income, environment, and culture.1,6  
Notable recent efforts, such as the Exercise is Medicine initiative7,8 are attempting to 
address the burden of chronic disease by calling upon primary care providers to begin 
prescribing exercise in their daily practice.  
Given the extensive burden of chronic diseases and recognizing the potential 
benefits of exercise, this thesis set out to determine: 1) who is adequately prepared to 
prescribe safe and effective exercise to those affected by chronic disease(s); 2) what 
factors need to be considered when prescribing exercise, and finally; 3) how can an 
exercise prescription be tailored to meet the unique and complex needs of those affected 
by more than a single disease.  
The “Who” of Exercise Prescription 
  Over the past decade compelling advocacy has been made for physicians9-14 to 
play a key role in exercise counseling and prescription, while others15,16 have suggested 
nurses incorporate exercise prescription as part of their health promotion mandate. 
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However, previous researchers17,18 found that medical schools from the United States and 
United Kingdom provide limited exercise education within their curriculum, with 
minimal opportunity to develop a specific exercise prescription. This thesis further builds 
upon this literature as it demonstrated the trend that medical and nursing programs in 
Canada also do not provide extensive (if any) exercise education as a mandatory 
component of their current curricula. However, a major finding that did emerge is that 
although medical (MD), nursing (RN), and physiotherapy (PT) students are taught 
general concepts about the benefits of exercise and could thus be exercise advisors or 
facilitators, only PTs know how to prescribe, implement, and modify exercise with all 
individuals, including those living with chronic disease(s). This means that significant 
curricula changes would need to be made in order to educate MD and RN students how to 
prescribe an appropriate exercise program, while PTs are already well prepared to take on 
this role by the time they complete their professional program.  
Although one strategy is to implement medical17-19 and nursing20 curricula 
changes that incorporate exercise as a mandatory component of their students’ education, 
resources may be better allocated to rely on primary care providers who already have 
extensive exercise prescription knowledge—physiotherapists. Even if curricula changes 
are implemented within medical and nursing programs their clinical practice context is 
more appropriate for exercise counseling or advising, rather than providing an 
appropriate, tailored exercise prescription to meet the needs of clients.14,20 
Physiotherapists on the other hand work within environments where exercise prescription 
is a fundamental component of their daily practice.21 Now that PTs are being included 
 
 
101 
within family health teams, there is a unique opportunity for them to make a meaningful 
contribution by effectively implementing exercise prescription in primary care.  
 Note however that while PTs may be best prepared to effectively implement 
exercise prescription in primary care, a challenge persists since there are limited 
opportunities for PTs to work in this clinical setting.22,23 Although PTs employed in 
primary care often develop group exercise programs for various populations, one-on-one 
care that may be necessary to tailor an exercise program for someone living with multiple 
chronic diseases still presents a potentially significant challenge. Currently, PTs working 
in Ontario primary care settings are sometimes expected to oversee the care of 500 to 
7000 clients.23 With less than 40 full-time equivalent PT primary care positions made 
available in Ontario, it can be reasoned that limited access to PT services will persist in 
this clinical practice context. Therefore, greater investment in primary care to increase the 
number of PTs that are made available to the public is worthwhile.  
It has also been reported that the elderly with chronic disease(s) mainly access 
publicly funded PT services24 and that MDs rarely refer clients for PT interventions due 
to the high cost associated with increasing sector of private PT care delivery.24,25 This 
barrier means that those who most often need and could benefit from PT services (i.e., 
elderly with chronic diseases) have limited access. In order to implement effective 
exercise prescription by the best prepared primary care providers—physiotherapists—and 
begin addressing the long called improvement in chronic disease prevention and 
management within primary care,6,26 there needs to be ongoing advocacy to improve 
access to publically funded PT services. This advocacy might benefit from capacity 
building to improve public and primary healthcare professionals understanding of PTs 
 
 
102 
scope of practice. Given that primary care MDs and RNs have previously indicated 
limited awareness of PTs scope and competencies, a number of individuals with chronic 
diseases who could benefit from PT are never referred for appropriate services.27 Thus, 
those in need would lose out on potentially beneficial PT interventions.    
The “What” of Exercise Prescription  
 This thesis also highlighted what factors should be monitored to ensure safety 
with exercise in individuals with multiple chronic diseases. The systematic literature 
review from this thesis showed that there were key overlapping physiological markers 
and subjective markers when a comparison of exercise recommendations is completed for 
three common chronic diseases: coronary artery disease (cardiovascular system), type 2 
diabetes mellitus (endocrine system), and chronic obstructive pulmonary disease 
(respiratory system). The concept behind this study was to begin looking at exercise 
prescription from a multi-system approach versus the currently dominant exercise 
guidelines, which take into account a single disease.28-32   
 The most common overlapping markers that emerged from this thesis include: 
systolic blood pressure, diastolic blood pressure, rate of perceived exertion, and heart 
rate. There are also overlapping markers and contraindications to exercise from multiple 
chronic diseases, alluding to a possibly innovative way for clinicians to prescribe and 
monitor limits of safe exercise for individuals with more than one chronic disease. 
Although researchers have provided examples of exercise prescription frameworks12,33  
this is the first attempt to integrate several chronic diseases to guide exercise-prescription 
decision-making. An algorithm was developed during this thesis to help guide clinicians 
when assessing individuals for disease-specific contraindications to exercise. For 
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instance, clinicians are guided on how to assess common physiological and subjective 
markers such as blood pressure, heart rate, and rate of perceived exertion, and then 
prescribe an appropriate exercise plan.  
Integration of the unique and overlapping markers that emerged from the 
systematic review suggest that it may be possible to tailor exercise programs to 
individuals with multiple chronic diseases, by taking into account key markers from each 
system. Future research considerations discussed later in this chapter elaborate more 
details about how this multi-system approach to exercise prescription can be further 
developed.  
The “How” of Exercise Prescription  
 A conceptual approach on how exercise prescription may be operationalized for 
individuals with chronic disease(s) within primary care emerged from this thesis. 
Although initiatives and exercise guidelines emphasize the importance of a tailored 
exercise prescription, there is little guidance on how this can be accomplished within 
primary care when working with individuals who have multiple chronic diseases. From 
the proposed exercise prescription approach in this thesis two main components emerged: 
1) the exercise prescription screening and 2) the exercise prescription tool.  
A major takeaway is that physicians and nurses, who are often the first point of 
contact, are well positioned within primary care to act as advisors or facilitators for 
exercise prescription, while physiotherapists ought to prescribe a tailored exercise 
program for the purpose of chronic disease management. Previous researchers34 have also 
suggested that reliance on allied health professionals, such as PTs for appropriate 
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interventions like exercise prescription, could decrease wait times to see a specialist and 
lead to improved functional outcomes (e.g., improved walking tolerance).  
The 5 A’s model, comprised of Ask, Advise, Assess, Assist, and Arrange 
elements is a tool that primary care providers such as MDs or RNs can use to advise 
clients about the benefits of exercise, as well as encourage or facilitate exercise 
participation. Researchers from Sweden have used a similar approach with the 5A’s 
model to assist the public in navigating their healthcare system and to promote exercise 
prescription.35 Thus, further research may show that it is possible to effectively 
implement the 5A’s model for exercise prescription within the Canadian context.  
Another point of discussion presented in this thesis is that a future electronic tool 
could be developed to expedite the screening of contraindications to exercise, while also 
incorporating social determinants of health when tailoring an exercise prescription for 
individuals affected by multiple chronic diseases. Although past guidelines have referred 
individuals to speak with their healthcare professionals for a tailored and appropriate 
exercise prescription, limited objective and systematic protocols are available for 
clinicians when designing personalized exercise prescriptions for those with multiple 
chronic disease(s).  
It has been previously shown that making a program meaningful to the individual, 
by taking into account their personal life context and also providing a printed exercise 
prescription sheet, is more effective at achieving exercise compliance when compared 
with solely providing advice to be active.36 Thus, the exercise prescription approach 
proposed in this thesis begins to address how broad exercise guidelines could be used in 
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order to personalize an exercise prescription to meet the unique needs of those affected 
by multiple chronic diseases.  
Limitations and Future Research Directions  
 Although care was taken to complete a comprehensive thesis report, there are 
several notable limitations that are discussed. First, the survey that was administered 
across Canada did not assess every professional program, but it solely focused on MDs, 
RNs, and PTs, limiting the generalizability of findings. Further caution with interpreting 
and generalizing findings ought to be taken regarding Canadian medical school exercise 
curricula due to the low response rate. The low response rate may be attributed to the 
timing (summer term) of survey distribution, as well as a potentially low priority of this 
exercise topic to medical schools. Also, the survey may have had greater buy-in from MD 
and RN programs if a fellow colleague from their respective profession administered the 
questionnaire, rather than a graduate student from a combined PT/PhD program.  
Second, the survey that was administered only takes into account the viewpoint of 
a single person (i.e., the program director) and could thus be at risk of bias to that 
participant. Third, the systematic review was limited by the use of the term “guideline”, 
as this decreased the number of possible randomized controlled trials that were found in 
the initial search results. Omitting this term in future database searches may produce a 
greater number of studies relevant for review. In addition, higher levels of evidence may 
be attained if a meta-analysis or a systematic review of previous systematic reviews was 
completed to enable collection and analysis of a greater breadth of data. These are all 
relevant and appropriate considerations for future research efforts in this area of study.  
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 There are additional directions to be considered with future research efforts. First, 
a survey of PT students’ perceptions of exercise prescription curricula offered during 
their education would provide important insight on how prepared they feel to prescribe 
exercise to individuals with chronic disease(s). On a related note, an evaluation could be 
completed to determine the confidence of PTs in primary care regarding development of 
exercise prescription interventions for individuals living with multiple chronic diseases. 
In addition to the three professional programs evaluated in this thesis, other primary care 
and/or alternative healthcare providers’ exercise curricula may be assessed to determine if 
there are additional clinicians who could contribute to the exercise prescription 
movement for those living with multiple chronic diseases. Kinesiologists’ potential role 
in exercise prescription within primary care is especially worth studying in the future 
given their recently increasing autonomy as regulated professionals.   
Future research may build on the systems-based exercise prescription concept 
introduced in chapter 3 of this thesis. Specifically, the systematic review illustrated the 
extensive complexity associated with extrapolating key physiological markers in order to 
tailor an exercise program for individuals with multiple chronic diseases. Due to this 
complexity, attempts at developing systematic guidelines for those affected by multiple 
chronic diseases has presented a considerable challenge. Limited time and funding 
restricted the ability to determine if key physiological markers could be identified and 
extracted from each of the 11 systems of the human body in order to determine a person’s 
physiological profile, regardless of the specific diseases present. Current exercise 
guidelines32,37 are designed with considerations of the generally healthy populations who 
fall within specific age ranges, or for those affected by a single disease. Within current 
 
 
107 
exercise guidelines,32 extensive recommendations are provided regarding 
contraindications to exercise when a specific disease is present, but little systematic 
guidance exists to assist clinicians in tailoring exercises for those with multiple chronic 
diseases. 
To further build upon the review completed in this thesis, future consideration 
should be given into looking at each system of the body to attempt extracting key markers 
associated with a high-risk event (i.e., severe injury or death) if the marker falls outside 
of its safe range. For example glucose would be considered a key marker associated with 
the endocrine system and if the levels are too low a person is at risk of hypoglycemia and 
possible death unless an appropriate intervention is provided. With this concept in mind, 
if major or key markers per system are extracted and classified per system, then tailoring 
an exercise prescription could be based on screening for these markers. As long as the 
key markers are in their safety zones then the person may be cleared for exercise and 
monitored over time, regardless of what specific disease(s) they have.  
Classification of each key marker affected with exercise into respective systems 
of the body may be possible in the future. For example, heart rate is a marker that is 
monitored in those with coronary artery disease, chronic obstructive pulmonary disease, 
and diabetes, but it would be classified into the cardiovascular system. Similarly to heart 
rate, blood pressure would also be classified under the cardiovascular system, while 
markers such as VO2 max and arterial oxygen saturation (SpO2) would be grouped under 
the respiratory system classification. Extensive research and screening of the most recent 
exercise guidelines could be done in the future to extract key factors across all major 
chronic diseases and then determine if these markers could be grouped within the body’s 
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major systems. The purpose of attempting such an approach would be to enable 
addressing how exercises could be tailored for those with multiple chronic diseases 
regardless of the disease(s) present. This may be possible, since the key markers from the 
body’s systems would be screened for safety, rather than checking each disease and 
reading separate contraindications associated with a single condition.  
Finally, if the exercise prescription electronic tool is developed in the future it 
could assist clinicians by expediting the exercise prescription process by quickly 
screening exercise contraindications, while also taking into account social determinants 
of health to make the prescription relevant to the individual’s life context.  However, 
future research ought to be done to validate the exercise prescription approach and tool 
introduced in chapter 4 of this thesis, before extensive resources are allocated into further 
tool development. Completing a Delphi study to determine whether the approach should 
be developed further would be the first step, followed by a process evaluation of a pilot 
study where the developed tool is implemented within primary care. An outcome 
evaluation could then be completed to determine the effectiveness of the exercise 
prescription approach and electronic tool. Ultimately too, the potential financial benefits 
to the current healthcare system need to be assessed. 
 
 
Conclusion 
 Key takeaways from this thesis are that although it has been previously advised to 
alter medical and nursing curricula to incorporate exercise education this restructuring 
approach would be difficult and unlikely represents the most efficient use of resources. 
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This thesis provides evidence that Canada’s primary care system already has 
physiotherapists who are well prepared to lead the exercise prescription movement for the 
purpose of chronic disease management. However, advocacy and funding support for PTs 
to be better integrated with publicly funded primary care settings is needed to enable 
people with chronic disease(s) to reap the benefits of tailored exercise prescriptions. 
Further efforts are also warranted to establish a systematic way to effectively 
guide exercise prescription for individuals affected by multiple chronic diseases. 
Although experiential clinical reasoning and collaboration with clients will continue to 
play an important role during the development of an exercise prescription, there ought to 
be more evidence-based, objective protocols that can more specifically guide decision-
making when working with individuals with multiple chronic diseases, rather than having 
to interpret and collate separate guidelines for each comorbid disease for every new 
client. Therefore, a systems-based approach may complement the currently dominant 
exercise guidelines that were developed to assist clinicians to prescribe an exercise 
program for a person with a single chronic disease. Ultimately, this systems-based 
approach poses an innovative way to begin addressing exercise prescription decision-
making for individuals with multiple chronic diseases.  
 In conclusion, due to the extensive personal and economic burden of chronic 
disease, incorporating precise exercise prescription from physiotherapy experts within 
primary care is a worthwhile endeavor. The barriers such as cost, time demands, limited 
access to PTs in primary care, and poor acceptance of physiotherapists’ role in chronic 
disease management need to be addressed by effective, determined advocacy from the 
profession. 
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Appendix B: Response Frequency 
 
Question 
Director 
Response (frequency)       
 Strongly 
Agree  
(%) 
Agree 
(%) 
Do Not 
Know (%) 
Disagree 
(%) 
Strongly 
Disagree 
(%) 
No 
Answer 
(%) 
Q1       
PT 10 0 0 20 70 0 
RN 0 10 0 60 30 0 
MD 0 25 0 50 25 0 
Q2       
PT 100 0 0 0 0 0 
RN 20 10 30 40 0 0 
MD 0 50 0 0 50 0 
Q3       
PT 100 0 0 0 0 0 
RN 0 10 0 80 10 0 
MD 0 0 0 75 25 0 
Q4       
PT 100 0 0 0 0 0 
RN 10 0 0 60 30 0 
MD 0 0 0 50 50 0 
Q5       
PT 80 20 0 0 0 0 
RN 10 10 10 60 10 0 
MD 0 0 0 50 50 0 
Q6       
PT 100 0 0 0 0 0 
RN 0 50 10 30 10 0 
MD 0 0 0 50 50 0 
Q7       
PT 100 0 0 0 0 0 
RN 0 50 0 50 0 0 
MD 25 25 0 25 25 0 
Q8       
PT 100 0 0 0 0 0 
RN 10 50 10 20 10 0 
MD 25 25 0 0 25 25 
Q10       
PT 90 0 0 0 0 10 
RN 10 70 0 20 0 0 
MD 0 75 0 0 25 0 
Q11       
PT 90 0 0 0 0 10 
RN 0 60 10 30 0 0 
MD 0 75 0 0 25 0 
Q13       
PT 60 0 0 10 0 30 
RN 20 0 0 60 20 0 
MD 25 50 0 0 25 0 
Q14       
PT 0 70 0 0 0 30 
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RN 10 10 10 50 10 10 
MD 25 50 0 25 0 0 
Q15       
PT 60 0 0 0 0 40 
RN 10 10 40 30 10 0 
MD 25 25 0 25 25 0 
* Q=question, thus Q1 represents Question 1 from the survey, etc.; PT=Physiotherapy 
Program Directors; RN=Nursing Program Directors; MD=Medical Program Directors.  
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Appendix C: t-test Tables 
 
Group Statistics           
 Profession N Mean Std. Deviation Std. 
Error 
Mean 
     
Q1 PT 10 4.4 1.265 0.4      
 RN 10 4.1 0.876 0.277      
Q2 PT 10 1 0 0      
 RN 10 2.9 1.197 0.379      
Q3 PT 10 1 0 0      
 RN 10 3.9 0.738 0.233      
Q4 PT 10 1 0 0      
 RN 10 4 1.155 0.365      
Q5 PT 10 1.2 0.422 0.133      
 RN 10 3.5 1.179 0.373      
Q6 PT 10 1 0 0      
 RN 10 3 1.155 0.365      
Q7 PT 10 1 0 0      
 RN 10 3 1.054 0.333      
Q8 PT 10 1 0 0      
 RN 10 2.7 1.252 0.396      
Q10 PT 9 1 0 0      
 RN 10 2.3 0.949 0.3      
Q11 PT 9 1 0 0      
 RN 10 2.7 0.949 0.3      
Q13 PT 7 1.43 1.134 0.429      
 RN 10 3.6 1.43 0.452      
Q14 PT 7 2 0 0      
 RN 9 3.44 1.236 0.412      
Q15 PT 6 1 0 0      
 RN 10 3.2 1.135 0.359      
* Q=question (Example: Q1 represents Question 1 from the survey); PT=Physiotherapy Program Directors; 
RN=Nursing Program Directors. 
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Independent Samples Test 
          
 
 
 
 Levene's Test for Equality of 
Variances 
 t-test for Equality of Means        
  F Sig. t Df Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
 
         Lower Upper 
Q1 Equal variances 
assumed 
0.72 0.409 0.617 18 0.545 0.3 0.486 -0.722 1.322 
 Equal variances 
not assumed 
  0.617 16.
014 
0.546 0.3 0.486 -0.731 1.331 
Q2 Equal variances 
assumed 
19.6 0 -5.019 18 0 -1.9 0.379 -2.695 -1.105 
 Equal variances 
not assumed 
  -5.019 9 0.001 -1.9 0.379 -2.756 -1.044 
Q3 Equal variances 
assumed 
3.76 0.068 -
12.429 
18 0 -2.9 0.233 -3.39 -2.41 
 Equal variances 
not assumed 
  -
12.429 
9 0 -2.9 0.233 -3.428 -2.372 
Q4 Equal variances 
assumed 
3.86 0.065 -8.216 18 0 -3 0.365 -3.767 -2.233 
 Equal variances 
not assumed 
  -8.216 9 0 -3 0.365 -3.826 -2.174 
Q5 
 
Equal variances 
assumed 
6.08 0.024 -5.811 18 0 -2.3 0.396 -3.132 -1.468 
 Equal variances 
not assumed 
  -5.811 11.
267 
0 -2.3 0.396 -3.169 -1.431 
Q6 
 
Equal variances 
assumed 
45 0 -5.477 18 0 -2 0.365 -2.767 -1.233 
 Equal variances 
not assumed 
  -5.477 9 0 -2 0.365 -2.826 -1.174 
Q7 Equal variances 
assumed 
. . -6 18 0 -2 0.333 -2.7 -1.3 
 Equal variances 
not assumed 
  -6 9 0 -2 0.333 -2.754 -1.246 
Q8 Equal variances 
assumed 
29.6 0 -4.295 18 0 -1.7 0.396 -2.532 -0.868 
 Equal variances 
not assumed 
  -4.295 9 0.002 -1.7 0.396 -2.595 -0.805 
Q 
10 
 
Equal variances 
assumed 
10.7 0.004 -4.099 17 0.001 -1.3 0.317 -1.969 -0.631 
 Equal variances 
not assumed 
  -4.333 9 0.002 -1.3 0.3 -1.979 -0.621 
Q 
11 
 
Equal variances 
assumed 
54.4 0 -5.36 17 0 -1.7 0.317 -2.369 -1.031 
 Equal variances 
not assumed 
  -5.667 9 0 -1.7 0.3 -2.379 -1.021 
Q 
13 
 
Equal variances 
assumed 
0.5 
 
0.49 -3.339 15 0.004 -2.171 0.65 -3.557 -0.785 
 Equal variances 
not assumed 
  -3.485 14.
672 
0.003 -2.171 0.623 -3.502 -0.841 
Q 
14 
Equal variances 
assumed 
13.2 0.003 -3.068 14 0.008 -1.444 0.471 -2.454 -0.435 
 Equal variances 
not assumed 
  -3.506 8 0.008 -1.444 0.412 -2.395 -0.494 
Q Equal variances 8.15 0.013 -4.68 14 0 -2.2 0.47 -3.208 -1.192 
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15 assumed 
 Equal variances 
not assumed 
  -6.128 9 0 -2.2 0.359 -3.012 -1.388 
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Appendix D: Sample search history for COPD from Scopus database 
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Appendix E: COPD Data Extraction 
 
Author 
 
Public
ation 
Year 
Article 
Title 
Level of 
Evidence 
Activity Type Freque
ncy 
Intensity Duration SpO2 
% 
HR 
bpm 
Respirat
ory Rate 
breaths/
min 
SBP 
mm
Hg 
DBP 
mmH
g 
RPE  
Bradley, J, 
et al.,47 
2009 Short-
term 
ambulaot
ry 
oxygen 
for 
COPD 
(Review) 
Highest 
level of 
evidence 
since Meta-
Analysis; 
Potential 
publication 
bias 
AT (e.g. 
treadmill, 
cycle 
ergometry, 
6MWT, step 
test, 
incremental 
walk test)  
   90% 131-
142  
 195-
210 
93-
101 
 
Corbridge, 
S, et al.,32  
2012 An 
Evidence
-Based 
Approac
h to 
COPD: 
Part 1 
 AT (Bicycle 
Ergometry and 
treadmill 
walking) 
 60-80% of 
maximal 
symptoms 
20 mins       
Costi, S, et 
al.,37  
2009 Effects 
of 
unsuppor
ted upper 
extremity 
exercise 
training 
in 
patients 
with 
COPD: 
A 
randomiz
ed 
clinical 
trial 
(RCT) 
The patients 
and PTs 
were not 
blinded. 
RT (UE 
strengthening- 
Shoulder 
Abduction, 
Deltoid lift in 
the scapular 
plane, Behind 
head tricep 
press, Bicep 
curls at 90 
degrees 
shoulder 
abduction, 
Bicep Curls 
 3 sets of 10 
reps 
progressin
g to 12 
reps then 
15 reps as 
long it was 
accomplish
ed with a 
Borg < 3; 
weight was 
increased 
by 500g 
once at 15 
reps; 50% 
X1 RM 
15 
sessions 
over 3 
weeks 
90.6 - 
92.5% 
79.7 - 
93.6 
20.9 - 
21.9 
  Dysp
nea 
Borg: 
1.72 - 
3.85; 
Fatigu
e 
Borg: 
1.24 - 
1.98 
Eves, ND, 
et al.,19 
2011 Evidence
-based 
Highest 
level of 
AT, Internal 
Training, RT 
3x/wk 
(AT); 
60-80% 
max 
Intervals 
of 30 -180 
>85%     4-6 
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risk 
assessme
nt and 
recomme
ndations 
for 
physical 
activity 
clearance
: 
respirator
y disease 
evidence 
since 
Systematic 
Review 
2-
3x/wk 
(RT) 
workload 
(AT); 80-
100% max 
workload 
(IT); 50-
80% 1RM 
(RT) 
seconds 
with either 
complete 
rest or 30-
40% 
workload 
max after 
interval; 
1-4 sets of 
6-12 reps 
(RT) 
Gupta, D, 
et al.,46  
2013 Guidelin
es for 
diagnosis 
and 
manage
ment of 
chronic 
obstructi
ve 
pulmonar
y 
disease: 
Joint 
ICS/NC
CP (I) 
recomme
ndations 
Highest 
level of 
evidence 
since 
Systematic 
Review 
AT; RT 15-45 
mins, 
daily to 
1x/wk 
50% max 
to 
maximum 
tolerable 
4-12 
weeks 
with 
greater 
benefit 
based on 
longer 
stay. 
      
Lacasse, 
Y, et al.,33 
2006 Pulmona
ry 
rehabilita
tion for 
chronic 
obstructi
ve 
pulmonar
y disease 
Highest 
level of 
evidence 
since 
Systematic 
Review 
AT 
(Pulmonary 
rehab: 
incremental 
cycle 
ergometer) 
At least 
4x/wk  
Maximal 
exercise 
capacity 7-
34 watts 
      3.3-
4.09/1
0 
Nonoyam, 
M, et al.,34 
2007 Oxygen 
therapy 
Highest 
level of 
AT (cycle 
ergometry 
2-3 
session
75-80% of 
peak work 
2-15 mins 
sessions; 
92-
95% 
125-
130 
30-34 187-
197 
87-94  
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during 
exercise 
training 
in 
chronic 
obstructi
ve 
pulmonar
y disease 
evidence 
since 
Systematic 
Review; 
Lack of 
homogeneity 
between the 
articles 
reviewed. 
The sample 
size in all 
studies 
reviewed 
were small 
which may 
underpower 
the overall 
effects. 
with oxygen) s/wk rate, 40-60 
watts 
> 3 wk of 
training 
Panos, RJ 2009 Exertion
al 
desaturat
ion in 
patients 
with 
chronic 
obstructi
ve 
pulmonar
y disease 
 AT (6MWT, 
treadmill and 
overground 
walking) 
         
Sharma, 
BB, et 
al.,20 
2011 Pulmona
ry 
rehabilita
tion: An 
overview 
 AT (Bicycle 
Ergometery 
and treadmill 
walking) 
2-3 
session
s/wk 
symptom 
limited, 
with goal 
of 80% 
max 
workload 
30-60 
mins for 
4-12 
weeks 
      
Zainuldin, 
R, et al.,48 
2011 Optimal 
intensity 
and type 
of leg 
exercise 
Highest 
level of 
evidence 
since 
Systematic 
AT & IT 
(Cycling, 
Treadmill and 
ground 
walking) 
 high versus 
low 
continuou
s (no 
breaks) vs. 
IT (1-3 
min 
 131-
134 
   7.2 - 
7.9 
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training 
for 
people 
with 
chronic 
obstructi
ve 
pulmonar
y disease 
Review breaks) 
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Appendix F: CAD Data Extraction  
 
Autho
r: 
Publica
tion 
Year 
Article 
Title 
Level of 
Evidence 
Activ
ity 
Type 
Freque
ncy 
Intens
ity 
Durati
on 
HR 
beats/
min 
SBP mmHg DBP mmHg Blood 
Glucose 
mmol/L 
RPE  
Bjarna
son-
Wehre
ns, B 
et al.,21 
2004 Recommend
ations for 
resistance 
exercise in 
cardiac 
rehabilitatio
n. 
Recommend
ations of the 
German 
Federation 
for 
Cardiovascu
lar 
Prevention 
and 
Rehabilitati
on 
 RT 2-
3x/wk 
for 6 
weeks 
30-
60% 
MVC 
1-2 sets 
5-15 
reps 
 Contraindicat
ion >160 
contraindicati
on>100 
 moni
tor 
for 
angi
na 
level 
Briffa, 
TG et 
al.,9 
2006 Physical 
activity for 
people with 
cardiovascul
ar disease: 
recommend
ations of the 
National 
Heart 
Foundation 
of Australia 
Most 
studies that 
were 
assessed 
for the 
paper 
predate the 
recent 
interventio
nal and 
pharmacol
ogical 
advances. 
The 
studies 
mostly 
involve 
AT most-
all 
days/w
k 
moder
ate 
30+min
/day 
 contraindicati
on<90 or 
>180 
contrindicatio
n <60 or >110 
cotraindic
ation <6 
or >15 
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men.  
Cornis
h, AK, 
et al.,31 
2011 Interval 
training for 
patients 
with 
coronary 
artery 
disease: A 
systematic 
review 
Highest 
level of 
evidence 
since 
Systematic 
Review;  
All trials 
reviewed 
had 
methodolo
gical flaws 
such as: no 
stat 
mentioned 
of 
intention 
to treat, 
inadequate 
reporting 
of patient 
comorbidit
ies, 
insufficient 
reporting 
about 
safety and 
interventio
n 
adherence 
and limited 
stats 
comparing 
adverse 
events 
between 
groups. 
Cautionabl
e external 
validity 
AT 2-
5x/wk 
70% 
VO2 
(low) - 
95%V
O2 
(high) 
30-60 
min 
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because of 
convenienc
e 
sampling. 
deJon, 
AT, et 
al.,36 
2006 Hemostatic 
responses to 
resistance 
training in 
patients 
with 
coronary 
artery 
disease 
(RCT) 
A control 
group was 
not used in 
the study 
therefore 
limiting 
the 
conclusion
s that can 
be drawn 
RT  12-14 
RPE 
8 
exercise
s, 1 set, 
10 reps 
monito
r 
monitor monitor  12-
14 
Lai, S 
et al., 
49 
2004 Treadmill 
scores in 
elderly men 
(RCT) 
Study is 
only 
generaliza
ble to 
elderly 
men. 
Selection 
bias. 
AT         Stop 
if 
>17 
Pavy, 
B et 
al.,11 
2010 French 
Society of 
Cardiology 
guidelines 
for cardiac 
rehabilitatio
n in adults 
 AT 3-
6x/wk 
12-14 
RPE 
30-60 
min 
10 
bpm 
below 
angina 
thresh
old 
<160   12-
14 
Perez-
Terzic, 
CM, et 
al.,12 
2012 Exercise in 
cardiovascul
ar diseases 
 AT/R
T 
AT=5-
7x/wk 
RT=2-
3x/wk 
AT=6
0-
70%V
O2 
RT=3
0-
60%M
VC 
AT= 
20-60 
min 
RT=1-3 
sets, 8-
12 reps 
want 
10bpm 
below 
angina 
level 
   moni
tor 
Vanhe
es, L, 
et al.,14 
2012 Importance 
of 
characteristi
RPE 
doesn't 
completely 
AT/R
T 
AT= 3-
5x/wk, 
start at 
AT=8
0-90% 
O2 
AT=30-
60 min 
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cs and 
modalities 
of physical 
activity and 
exercise in 
the 
management 
of 
cardiovascul
ar health in 
individuals 
with 
cardiovascul
ar disease 
(Part III) 
correlate 
with 
myocardial 
function. 
RPE can 
be 
influenced 
by 
psychologi
cal factors 
such as: 
group 
dynamics, 
depression, 
motivation 
and 
experience 
with 
exercise. 
40% 
HR 
reserve 
and 
increas
e to 
60%;  
RT=2-
3x/wk 
uptake
, RT= 
30-
70% 
1RM 
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Appendix G: Diabetes Data Extraction 
 
Auth
or: 
Public
ation 
Year 
Article 
Title 
Level of 
Evidence 
Activit
y Type 
Frequ
ency 
Intensi
ty 
Duratio
n 
HR 
beats/
min 
SBP 
mmHg 
DBP 
mmH
g 
Blood 
Gluc
ose 
mg/dl 
ME
TS 
HbA1C RPE  
Araiz
a, P. 
et al23 
2006 Efficacy of 
a 
pedometer-
based 
physical 
activity 
program 
on 
parameters 
of diabetes 
control in 
type 2 
diabetes 
mellitus 
(RCT) 
5/10 PEDro 
score 
AT 
(walki
ng) 
Everyd
ay 
 10,000 
steps 
per day 
using a 
pedomet
er 
      
 
Baldu
cci, S, 
et 
al.,38  
2012 Effect of 
High- 
versus 
Low-
Intensity 
Supervised 
Aerobic 
and 
Resistance 
Training 
on 
Modifiable 
Cardiovasc
ular 
Risk 
Factors in 
Type 2 
Diabetes; 
The Italian 
5/10 PEDro 
score 
AT; 
RT 
 Low: 
55% 
max 
VO2 
(AT); 
60% 
1RM 
(RT). 
Moder
ate: 
70% 
max 
VO2 
(AT); 
60% 
1RM 
(RT) 
      improve
d, 
higher 
intensit
y better 
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Diabetes 
and 
Exercise 
Study 
(IDES) 
(RCT) 
Colbe
rg, S. 
et 
al.,6 
2010 Exercise 
and Type 2 
Diabetes 
(SR) 
Highest 
level of 
evidence 
since 
Systematic 
Review 
AT; 
RT 
3x/wk 
with no 
more 
than 2 
consec
utive 
days 
off 
(AT); 
2x/wk 
on non 
consec
utive 
days 
(RT) 
Low: 
40-
60% 
max 
VO2 or 
High: 
>60% 
max 
VO2 
(AT); 
Mod: 
50% 
1RM 
or 
Vigoro
us: 75-
80% 
1RM 
Minimu
m of 
150 min 
/wk in 
bouts of 
10 min 
or 
longer 
(AT) 
   >100 
- 
<300 
mg/dl 
  
 
Hayes
, C. et 
al24 
2008 Role of 
Physical 
Activity in 
Diabetes 
Manageme
nt and 
Prevention 
(Review) 
 AT 150 
minute
s/wk 
     decre
ased 
BG 
levels 
post 
meal 
  
 
Hills, 
AP, et 
al.,39 
2010 Resistance 
training for 
obese, type 
2 diabetic 
adults: 
a review of 
the 
evidence 
Limited 
external 
validity for 
certain 
ethnic 
groups and 
patients 
with T2DM 
AT; 
RT 
 60-
85% 
max 
VO2 or 
max 
HR 
(AT); 
60-
15-75 
mins 
(AT) 
Max: 
max 
HR 
(Age 
predic
ted) 
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(review) age < 35 80% 
1RM 
(RT) 
Krous
el- 
Wood
, MA, 
et al25 
2007 Does 
home-
based 
exercise 
improve 
body mass 
index in 
patients 
with type 2 
diabetes? 
Results of 
a 
feasibility 
trial (RCT) 
Potential 
confoundin
g variables 
of other risk 
factors not 
assessed/co
ntrolled in 
the study. 
Diet was 
not 
controlled 
which could 
affect the 
results. 
AT 5x/wee
k 
 30 
mins/da
y 
    3-6   
 
Lim, 
J.G., 
et al26  
2004 Type 2 
Diabetes in 
Singapore: 
The role of 
Exercise 
Training 
for its 
Prevention 
and 
Manageme
nt (review) 
 AT  1000 
kcal/ 
wk  
    impro
ved 
  
 
Madd
en 
K.M.7 
2013 Evidence 
for the 
benefit of 
exercise 
therapy in 
patients 
with type 2 
diabetes 
(Review) 
Evaulate 
how 
different 
ethnic 
populations 
respond to 
the standard 
recommend
ations for 
exercise 
AT    > 150 
min a 
week 
     -0.89% 
 
Marw
ick, 
2009 Exercise 
Training 
Highest 
level of 
AT 
(tread
5 
days/w
 20-30 
mins 
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T.H. 
et al8 
for Type 2 
Diabetes 
Mellitus 
Impact on 
Cardiovasc
ular Risk 
(SR) 
evidence 
since 
Systematic 
Review 
mill) k 
Misra
,A. et 
al.,35 
2012 Consensus 
Physical 
Activity 
Guidelines 
for Asian 
Indians 
(Review) 
Limited 
external 
validity to 
other 
populations 
RT > 
3days/
wk 
10 reps     > 70 - 
< 300  
  
 
Norri
s 
Susan
, H., 
et 
al.27  
2005 Long-term 
non-
pharmacol
ogical 
weight loss 
interventio
ns for 
adults with 
type 2 
diabetes 
mellitus 
(SR) 
The 
intervention
s in studies 
compared 
were 
hetergeneou
s limiting 
quantitative 
syntheses. 
Attrition 
bias; 
potential 
sampling 
bias 
because of 
small 
sample 
sizes 
AT 2x/wk 
in 
group 
and 
1x/wk 
on 
own; 
walked 
3 miles 
4x/wk 
Moder
ate 
3 miles  decreas
ed 
decre
ased 
  -1.0% 
to 2.6% 
 
Nyen
we, 
EA, 
et 
al.,28  
2011 Manageme
nt of type 
2 diabetes: 
Evolving 
strategies 
for the 
treatment 
of patients 
 AT 3x/wk Moder
ate 
50 mins      -0.70% 
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with type 2 
diabetes 
(review) 
Praet, 
SFE, 
et 
al.,40 
2009 Exercise 
therapy in 
Type 2 
diabetes 
(review) 
 AT; 
RT 
3x/wk; 
no 
more 
than 2 
consec
utive 
days 
w/o 
activity 
Moder
ate or 
vigour
ous 
(AT); 
3 sets 
of 8-10 
reps 
targeti
ng all 
major 
muscle 
groups 
150 
min/wk 
or 90 
min/wk 
 decreas
ed 4.16 
 impro
ved 
 improve
ment > 
7.4% 
 
Ridde
ll, 
MC, 
et al., 
29 
2011 Evidence-
based risk 
assessment 
and 
recommen
dations for 
physical 
activity 
clearance: 
diabetes 
mellitus 
and related 
comorbidit
ies (SR) 
Conclusions 
about the 
probability 
of adverse 
events is 
limited 
because the 
many 
studies 
reviewed 
screened 
out patients 
with 
comorbiditi
es or had s/s 
of 
myocardial 
insufficienc
y 
AT 
(cyclin
g) 
5x/wee
k 
75% 
VO2 
max 
30-40 
mins/da
y, min. 
20 mins 
sessions 
 < 260 
mmHg 
< 115 
mmH
g 
 < 6 -0.60% 
10-
13/20 
or 3-
6/10 
Sigal, 
RJ, et 
al.,13 
2004 Physical 
activity/ex
ercise and 
type 2 
diabetes 
 AT; 
RT (on 
all 
major 
muscle 
3x/wk 
(AT 
and 
RT) 
Moder
ate: 
50-
70% 
max 
150 
min/wk 
or 90 
min/wk. 
5 min 
 < 200 
for 
people 
with 
neurop
decre
ased 
2.58 
>100    
mode
rate 
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(review) groups
) 
HR or 
40-60 
VO2 
max. 
Vigoro
us: > 
70% 
max 
HR or 
> 60% 
VO2 
max 
(AT); 
1 set of 
10-15 
reps 
progre
ssing 
to 3 
sets of 
8-10 
reps of 
1RM 
warm 
up and 
cool 
down 
for AT 
and RT 
athy; 
decreas
ed 3.84 
Stewa
rt, KJ, 
et 
al.,41 
2004 Role of 
exercise 
training on 
cardiovasc
ular 
disease in 
persons 
type 2 
diabetes 
and 
hypertensi
on 
(review) 
 AT; 
RT  
2x/wk  Target 
55-
79% 
max 
HR or 
50-
60% if 
low 
fitness 
level 
(AT). 
Light 
to 
moder
ate: 
30-
50% 
1 sets 
minimu
m of 8-
10 reps 
     -0.66% 
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1RM 
Sukal
a, 
WR.,4
2 
2012 Exercise 
interventio
n in New 
Zealand 
Polynesian 
peoples 
with type 2 
diabetes: 
Cultural 
considerati
ons and 
clinical 
trial 
recommen
dations 
(review) 
High 
attrition rate 
and low 
intervention 
adherence 
rate 
AT 
(cycle 
ergom
eter); 
RT (8 
differe
nt 
muscle 
groups
) 
3x/wk 65-
85% 
HR 
reserve 
(AT); 
6-8 
reps, 1 
min 
rest 
betwee
n sets 
40-60 
mins 
      
"very 
hard" 
or 
17/20 
Wary
asz, 
GR.,4
3 
2010 Exercise 
prescriptio
n and the 
patient 
with type 2 
diabetes: A  
clinical 
approach 
to 
optimizing 
patient 
outcomes 
(review) 
 AT (tai 
chi, 
yoga, 
walkin
g); RT 
5x/wk 
total of 
AT and 
RT; 10 
miles 
walkin
g/wk 
(AT) 
40-
70% 
VO2 
max 
(AT); 
Low to 
moder
ate: 
worklo
ads 50-
74% 1 
RM. 
High: 
>74% 
1RM 
minimu
m 30 
min/day
. 60-90 
mins/da
y (For 
wt loss 
or 
mainten
ance) 
      
11-15 
"light
-
hard" 
Welt
man, 
NY, 
et 
al.,44  
2009 The use of 
exercise in 
the 
manageme
nt of type 
1 and type 
2 diabetes 
(review) 
 AT; 
RT (all 
major 
muscle 
groups
) 
3-
5x/wk 
Mod: 
40/50 
to 85% 
of HR 
reserve
. Vig: 
64/70
% to 
150 
mins/wk 
moderat
e 
intensity 
OR 75 
min/wk 
at 
 decreas
ed 
decre
ased 
> 100 
- < 
300 
  
12-16 
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94% of 
HR 
max 
(AT); 
Moder
ate to 
high of 
8-12 
reps 
vigorou
s 
intensity
. > 10 
mins 
sessions
. 
Whyt
e, J, 
et 
al.,45  
2013 Exercise 
for patients 
with 
diabetic 
peripheral 
neuropathy
: Getting 
off on the 
right foot 
(review) 
 AT 
(brisk 
walkin
g, 
swimm
ing, 
station
ary 
biking, 
ellipiti
cal); 
RT 
(legs, 
chest, 
back) 
3x/wk. 
Aim 
for 150 
mins/w
k (AT); 
2x/wk 
(RT) 
40-60 
VO2 
max 
(AT); 
mod to 
vigour
ous 
(RT) 
Minimu
m 10 
min 
bouts 
(AT); 5-
10 
exercise
s at 10-
15 reps 
(RT) 
   decre
ased 
  
 
Youn
k, 
LM, 
et al., 
30 
2011 Exercise-
related 
hypoglyce
mia in 
diabetes 
mellitus 
(review) 
 AT 3-4/wk 50-
70% 
VO2 
max 
150 
mins/wk 
   >100   -0.38 to 
-0.51 
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Appendix H: Studies and reasons for exclusion from the systematic literature review  
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Appendix I: Physiological Profile Data Sheet 
(Note: This sheet can complement data attained via Electronic Medical Record) 
 
Condition  Contraindications  Signs and Symptoms of 
Contraindications  
 Exercise Prescription 
Options  
T2DM Autonomic neuropathy   Dizziness and fainting. 
• Urinary problems 
• Sexual difficulties 
• Difficulty digesting food 
• Sweating abnormalities 
• Sluggish pupil reaction 
• Exercise intolerance 


☐
☐

☐

Type: Aerobic Training 
Intensity: moderate 
Frequency: 3-7 days 
per week  
Duration: 30-60 
minutes per day  
Type: Resistance 
Training (major muscle 
groups ~ 8 exercises)  
Intensity: 30-70% of 
one repetition 
maximum 
Frequency: 1-4 sets, of 
5-15 repetitions per 
exercise  
Duration: 2-3 days per 
week  
 Severe peripheral neuropathy 
☐ 
• numbness and tingling in  
feet or hands; may spread into 
legs and arms 
• Sharp, jabbing or burning 
pain 
• Extreme sensitivity to touch 
• Lack of coordination/falling 
• Muscle weakness or 
paralysis  
☐

☐
☐
☐
☐
 
 Pre-or-Proliferative 
retinopathy ☐ 
• Spots/dark strings floating 
in your 
vision (floaters) 
• Blurred vision 
• Fluctuating vision 
• Impaired color vision 
• Dark or empty areas in you 
vision 
• Vision loss 
☐
☐
☐
☐
☐
☐
 
CAD Unstable  
Angina ☐ 
• Chest pain or discomfort 
• arms, neck, jaw, shoulder 
or back 
pain with chest pain 
• Nausea 
• Fatigue 
• Shortness of breath 
• Sweating 
• Dizziness 
☐
☐
☐
☐
☐
☐
☐
Type: Aerobic Training 
Intensity: moderate 
Frequency: 3-7 days 
per week  
Duration: 30-60 
minutes per day  
Type: Resistance 
Training (major muscle 
groups ~ 8 exercises)  
Intensity: 30-70% of 
one repetition 
maximum 
Frequency: 1-4 sets, of 
5-15 repetitions per 
exercise  
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Duration: 2-3 days per 
week 
 Uncontrolled arrhythmia ☐ • A “fluttering” sensation in 
chest 
• A racing heartbeat 
(tachycardia) 
• A slow heartbeat 
(bradycardia) 
• Chest pain 
• Shortness of breath 
• Lightheadedness 
• Dizziness 
• Fainting (syncope) or near 
fainting 
• Fatigue 
☐
☐
☐
☐
☐
☐
☐
☐
 
 Heart failure ☐ • Shortness of breath that 
makes it 
difficult to talk or finish an 
activity 
• Unusual or excessive 
fatigue, 
weakness or faintness 
• Pulse feels fast or irregular, 
or 
sensation of feeling the heart 
beat 
• Waking in the night 
coughing, 
feeling short of breath or 
gasping for air 
• Sudden or unexpected 
weight gain 
• Dizziness or light-
headedness 
• Swollen feet, ankles, 
fingers, legs or 
abdomen 
• Need to urinate frequently 
at night 
• Loss of appetite 
☐

☐

☐

☐


☐
☐

☐
 
☐ 
☐
 
 Stenotic/uncompensated valve 
☐ 
• Chest pain (angina) or 
tightness 
• Feeling faint or fainting 
with 
exertion 
• Shortness of breath, 
especially with 
exertion 
• Fatigue, especially during 
times of 
increased activity 
• Heart palpitations — 
sensations of a 
rapid, fluttering heartbeat 
• Heart murmur 
☐
☐

☐
 
☐ 
☐ 
☐ 
 
☐
 
 Hypertrophic obstructive • Shortness of breath, ☐  
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cardiomyopathy ☐ especially 
during exercise 
• Chest pain, especially 
during 
exercise 
• Fainting, especially during 
or just 
after exercise or exertion 
• Sensation of rapid, 
fluttering or 
pounding heartbeats 
(palpitations) 
• Heart murmur, which a 
doctor might 
detect while listening to your 
heart 
 
☐

☐
 
☐ 
 
☐ 

COPD  Severe HTN ☐ • Severe chest pain 
• Severe headache, 
accompanied by 
confusion and blurred vision 
• Nausea and vomiting 
• Severe anxiety 
• Shortness of breath 
• Seizures 
• Unresponsiveness 
☐
☐
☐
☐ 
☐ 
☐ 
☐ 
☐ 
Type: Aerobic Training 
Intensity: moderate 
Frequency: 3-7 days 
per week  
Duration: 30-60 
minutes per day  
Type: Resistance 
Training (major muscle 
groups ~ 8 exercises)  
Intensity: 30-70% of 
one repetition 
maximum 
Frequency: 1-4 sets, of 
5-15 repetitions per 
exercise  
Duration: 2-3 days per 
week 
 Hypoxemia ☐ • Blue or cherry red skin tone  
• Confusion 
• Cough 
• Fast heart rate 
• Rapid breathing 
• Shortness of breath 
• Sweating 
• Wheezing 
☐
☐
☐
☐ 
☐ 
☐ 
☐ 
☐
 
 Unstable angina ☐ • see CAD unstable angina   
 Congestive hearth failure ☐ • see heart failure   
 Summary of the algorithm aimed to process the physiological profile data 
ConditionScreen Contraindications (from EMR/questionnaire/diagnostics)screen Signs and 
symptomscontraindications cleared Exercise Prescription based on physiological profile: 
  
    Type: AT, RT (all major muscle groups ~ 8 exercises); AT+RT 
    Intensity: AT=moderate; RT: 30-70%of 1 repetition max  
    Frequency: AT=3-7 days per week; RT: 1-4 sets, 5-15 repetitions  
    Duration: AT=30-60 min per day; RT: 2-3 days per week 
Contraindications NOT clearedGuide client to resolution options (Pharmacological; Surgical; Medial 
consult; Counseling; Alternative Medicine)IF contraindication cleared proceed to exercise 
prescriptionIF contraindication cannot be cleared provide safe alternatives (e.g., symptom free and 
unstructured activity such as walking, gardening, etc.)  
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Appendix J: Sample of a personal profile questionnaire 
 
Please check off all appropriate boxes. 
1) Postal Code  
2) To attend appointments I am willing to travel:  
☐ ≤ 5 km  
☐ 6-20 km  
☐ 21-40 km  
☐ 51- 100km  
☐ >100km 
3) To attend appointments I:  
☐ drive  
☐ use the transit  
☐ am driven by a special transit service provider (e.g., Wheel-trans)  
☐ use taxi services 
☐ am driven by my friend/family/other  
Note: GPS technology can be employed to guide the use of data collected from questions 1-3. For example 
clients can be directed to an appropriate services in their community within a designated radius depending 
on client’s mode of transportation and the distance they are willing to travel to attend appointments.  
4) Employment status  
☐ full-time employment  
☐ part-time/casual employment  
☐ unemployed  
☐ on ODSP (Ontario Disability Support Program  
☐ on welfare   
☐ student  
5) How much can you afford to spend on an exercise intervention:  
☐ $0.00 
☐ $ <500/year  
☐ $ 500-1000/year  
☐ $ >1000/ year 
Note: Question 4-5 may inform the exercise options available to the client, (e.g., free, government-funded, 
private care)  
6) Age Range  
☐≤18  
☐ 19-65 
☐>65 
7) Activity preference. If you were to exercise what would you prefer:  
☐ exercising in a group 
 ☐ males only  
 ☐ females only  
 ☐co-ed 
☐ individual exercise  
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 ☐ by myself at home with appropriate instructions (written or digital)  
 ☐ in an appropriate facility (e.g., gym, community center)  
 ☐with an appropriate instructor (one-on-one)  
☐ aerobic exercise  
 ☐ running 
 ☐ cycling  
 ☐ swimming 
 ☐ sports (tennis, volleyball, basketball, etc.)  
 ☐ other   
 ☐ resistance training  
 ☐ lifting weights  
 ☐ calisthenics (using own body weight: lunges, sit-ups, push-ups, squats)  
☐ combined exercise  
 ☐ circuit training  
 ☐ mixing different aerobic and resistance training activities  
 ☐ other (yoga, stretching, tai-chi, etc.)    
 
Note: data collected by questions 6 may inform clients’ eligibility for certain exercise interventions that are 
designed for a certain age-range (e.g., senior classes), while question 7 aims to collect data regarding 
client’s activity preference to inform the clinician when designing a tailored exercise prescription. 
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Appendix K:  Exercise Curricula Questionnaire 
Copy of the electronic questionnaire that was e-mailed to physiotherapy, nursing, and 
medical program directors across Canada.  
 
Unless otherwise indicated, please provide one response to each question.  For the 
"Other (Please Specify)" option(s) you may provide as much information as you feel 
is necessary to reflect your thoughts as there are no word limits.   Please note that 
"we/our" in this survey refers to the perspective of your professional program (e.g., 
medical, nursing, physiotherapy) at your institution (e.g., Western, UofT, Queens, 
McGill, etc).     
 
1. We believe that giving advice to be physically active is the same as providing 
a specific exercise prescription: 
Strongly Agree   Agree   Do Not Know   Disagree   Strongly 
Disagree 
2. We believe that teaching students how to prescribe exercises to clinical 
populations should be mandatory:  
Strongly Agree   Agree   Do Not Know   Disagree   Strongly 
Disagree 
3. We teach students how to design an exercise program for individuals living 
with medical conditions. 
       Strongly Agree   Agree   Do Not Know   Disagree   Strongly 
Disagree 
4. We teach our students to prescribe exercise(s) using specific criteria (e.g., 
frequency, intensity, sets, repetitions, duration, etc.)  
Strongly Agree   Agree   Do Not Know   Disagree   Strongly 
Disagree  
5. We teach our students how to implement an exercise program. 
Strongly Agree   Agree   Do Not Know   Disagree    Strongly 
Disagree 
6. We teach our students established exercise precautions. 
Strongly Agree   Agree   Do Not Know     Disagree   Strongly 
Disagree 
7. We teach our students established exercise contraindications. 
Strongly Agree   Agree    Do Not Know    Disagree   Strongly 
Disagree 
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8. We teach our students what to monitor to ensure safety during exercise.  
Strongly Agree   Agree    Do Not Know    Disagree   Strongly 
Disagree 
9. In order to teach our students specific physical activity recommendations, we 
use exercise guidelines from the following (check all that apply):  
 We do not use any established guidelines  
 American College of Sports Medicine 
 Canadian Physical Activity Guidelines         
 Canadian Society for Exercise Physiology  
 Other (please specify) 
10. Our students are taught how to advise patients about the benefits of exercise: 
Strongly Agree   Agree   Do Not Know    Disagree   Strongly 
Disagree 
11. We have dedicated lectures to teach our students the physiological effects of 
exercise on chronic disease(s):  
Strongly Agree    Agree   Do Not Know   Disagree    Strongly 
Disagree 
12. We teach our students how to prescribe exercises to populations living with 
the following (check all that apply) 
Type I Diabetes     
Type II Diabetes  
Coronary Artery Disease  
Stroke 
Multi-System Involvement      Other (please specify) 
13. We have at least one course dedicated to teaching students about the 
benefits of physical activity/exercise:  
Strongly Agree  Agree   Do Not Know    Disagree    Strongly 
Disagree 
14.  Exercise prescription is integrated within mandatory courses:  
Strongly Agree   Agree   Do Not Know   Disagree   Strongly 
Disagree 
15. Our curriculum provides a sufficient amount of exercise/physical activity 
instruction:  
Strongly Agree   Agree    Do Not Know    Disagree  Strongly 
Disagree 
16. In the next 5 years we plan to have a course dedicated to teaching our 
students how to prescribe exercise/physical activity to clinical populations 
[i.e., individuals living with chronic condition(s)] 
Yes    No     We already have such a course    Do Not Know   
 
Other (please specify)    
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17.  Please indicate the province where your institution is situated and share any 
additional thoughts/comments.   
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4) Hovanec N, Sawant A, Oerend TJ, Petrella RJ, Vandervoort AA. Resistance training 
and older adults with type 2 diabetes mellitus: strength of the evidence. Journal of 
Aging Research 2012; 2012, pp. 1-12 (published) 
5) Kothari A, Hovanec N, Hastie R, Sibbald S. Knowledge management in health care: 
lessons from the business sector. BMC Health Services Research 2012 (11): 173 
(published)  
6) Hovanec N, Overend T, Vandervoort A. The how of exercise prescription in primary 
care: a proposed approach (in preparation).  
 
B. PRESENTATIONS  
 
1) Discussion Panel Member: presentation of experiences gained as a 
community physical therapist working with marginalized 
communities in Toronto. Answered fourth year undergraduate 
students’ questions and contributed to the overall discussion. (York 
University, Health Promotion Course, Toronto, ON)  
2) Poster Presentation: Bellemore D., Kuhnow J, Miller F, van Vloten A, 
Hovanec N, Vandervoort AA. “A novel systems-based approach 
using physiological markers from CAD, COPD, and type 2 diabetes 
for exercise prescription for individuals with multiple chronic 
diseases: systematic review.” (Western University, London, ON)   
3) Poster Presentation: Hovanec N., Overend, T., Petrella, R., 
Vandervoort, A. “Study Proposal for Exercise Prescription in 
Complex Patients”. School of Physical Therapy Research Day. 
(Western University, London, ON) 
4) Oral Presentation: Hovanec N. “Strength of the Evidence, Resistance 
Training and Older Adults with Type 2 Diabetes”. Health and Aging 
Seminar. (Western University, London, ON) 
 
16/08/15 
 
 
 
 
18/07/14 
 
 
 
 
 
19/07/13 
 
 
 
04/04/11 
5) Oral Presentation: Hovanec N. “A Project to Develop and Pilot Test 
Tools for Knowledge Management in Public Health Units”. (The 
Tenth International Conference on Knowledge, Culture & Change in 
Organizations, Montreal, QC.) 
27/07/10 
6) Oral Presentation: Hovanec N. “Knowledge Management Tools: An 
Introduction”.  (Huron, Clinton, Region of Peel, and York Region 
13/04 – 17/06 
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Public Health Units, ON) 
7) Oral Presentation: Hovanec N. “Knowledge Management Tools: A 
pilot study in public health” (Public Health Unit, Huron, ON) 
 
05/05/10  
8) Guest lecturer: Hovanec N. “Designing Evaluation: Types of 
Program Evaluation”. (Western University, London, ON) 
9) Poster Presentation: Harlos, K., Kothari, A., Ritchie, J., Taylor, L., 
Angus, D., Baxter, J., Hovanec, N., and Bird, M. “Using management 
knowledge to advance knowledge implementation in health care: 
scoping the literature”. (Manitoba Centre for Health Policy 20th 
Anniversary Conference, Winnipeg, MB) 
11/01/10 
 
08 – 09/03/10  
10) Workshop facilitator: “Developing a Toolbox for Tacit Knowledge 
Management in Public Health”. (Canadian Public Health Association 
2009 Annual Conference, Winnipeg, MB) 
 
4 CLINICAL EXPERIENCE   
08/06/09 
 
 
 
 
 
A. EMPLOYMENT  
 
Closing The Gap Healthcare Group (Toronto, ON) 
 Clinical Practice Context: Community (Physiotherapist)  
 Responsibilities: assessments, diagnosis, treatment, discharges; 
improve clients’ functional mobility through education, exercise 
prescription, and use of appropriate modalities; connecting and 
referring clients to necessary services; supervise PTAs. 
 Caseload: diverse (people with 
MSK/orthopaedic/neurological/multi-system needs)  
 
B. CLINICAL PLACEMENTS  
 
 
 
31/03/14 – Present 
 
 
 
 
 
 
 
 
 
West Perry Sound Health Center (Perry Sound, ON)  
Clinical Practice Context: Acute Care  
 
Veterans Care Program, Parkwood Hospital (London, ON)  
Clinical Practice Context: Rehabilitation  
 
CBI—Physiotherapy & Rehabilitation Center  (London, ON)             
Clinical Practice Context: Orthopaedics/Clinics  
 
Unit A3: Neuro-Oncology, St. John’s Rehabilitation Center 
(Toronto, ON)  
 
Clinical Practice Context: Rehabilitation  
 
Bruce County Physiotherapy and Sport Injuries Clinic (Port 
Elgin, ON); & Sauble Beach Physiotherapy Clinic (Sauble Beach, 
ON) 
 
 Clinical Practice Context: Orthopaedics/Clinics  
07/13 – 08/13 
 
 
04/13 – 06/13 
 
 
03/13 – 04/13 
 
 
 
10/12 – 12/12 
 
 
 
06/12 – 07/12 
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5. DEVELOPMENT ACTIVITIES 
In-service Training/Workshops  
 Brain Gym—St. John’s Rehabilitation Center (Toronto, ON) 
 Kinesio Taping—Parkwood Hospital (London, ON) 
 Vision Rehab—Parkwood Hospital (London, ON) 
 Manual Muscle Testing—Parkwood Hospital (London, ON) 
 Documentation/Record Keeping—Parkwood Hospital (London, ON) 
Certification  
 Soft Tissue Release Certificate (London, ON) 
 York University Sports Administration Association Certificate 
(Toronto, ON)  
 NDT/Bobath Certificate (Toronto, ON) 
 
 
 
12/12 – 06/13 
 
 
 
 
 
 
27/01/13 
06/2007 
 
(Fall: 2015) 
 
6. HONOURS  
 
 Western Graduate Research Scholarship, Western University, Ontario 2008 — 15  
 Graduate Teaching Award Nominee, Western University, Ontario  2010 
 Dean’s Honour Roll, York University  2007 
 Customer Service Award, Shoppers Drug Mart  2007 
 Entrance Scholarship, York University  2002 
 
7. VOLUNTEER 
 
 
  
 Mili Fay Art “Together we support the world one artwork at a time”  2011 – Present  
 INFUSION Canada, a registered charity for cancer survivors  03/03/11 
 William Osler Health Center Etobicoke Hospital Campus, Canada 
 Dom Zdravlja (Health Center), Belgrade, Serbia 
05/05 – 08/05 
06/04 – 09/04  
 
8. HOBBIES    
 
 
 Recreational activities (I love contemporary dance, volleyball, tennis, being active)  
 Meditation & Yoga (always helps me recharge, re-energize, and gain perspective)  
 Finally, I love traveling, reading, socializing, the arts, and living life to the fullest!  
 
 
PROFILE SUMMARY  
 
 
 Member of the Canadian Physiotherapy Association (2011-present) in the following 
divisions: Orthopaedic, Neuroscience, Pain Science, Seniors Health.  
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 Proven ability to multi-task and complete high caliber projects.  
 Achieved publications of highly accessed articles. 
 Exceptional collaboration with clients and colleagues with over 10+ years of work 
experience as a member of diverse teams.  
 One of two students accepted into the combined MPT/PhD at Western, 2010. 
 Recognized for volunteering in different cultural and organizational contexts.  
